close

April 2022

Prescription drugs

Pharmacists offer hay fever sufferers over-the-counter prescription medications

Hay fever sufferers in Somerset can now get prescription-only over-the-counter medication from local pharmacies. Community pharmacies are stepping up support for those suffering from the seasonal illness, with some allergy medications previously only available on prescription now being offered over the counter.

The changes aim to make it easier for people with severe hay fever symptoms to get the help they need without having to make an appointment with a GP or go to an urgent care department . Dr Shaba Nabi, local GP and clinical lead for prescribing at Bristol, North Somerset and South Gloucestershire Clinical Commissioning Group, said: “Every year many GP practices and even A&E departments, see of people with persistent symptoms of hay fever.

“This year, we want to enable users to access the right support at the right time as quickly and easily as possible. That’s why we’ve made changes to our primary care services, with community pharmacies now able to provide hay fever medicines that were previously only available on prescription.

READ MORE:Campaign group’s stern warning to owners of Bristol airport

“The changes will make it easier for people to get short-term specialist assistance, while freeing up GP appointments and reducing unnecessary visits to urgent and emergency healthcare services.” In the UK, more than one in four people are affected by hay fever.

Although this is only a nuisance for most people, it can be very inconvenient for others, preventing people from enjoying the outdoors. There are steps you can take to alleviate the negative symptoms of hay fever.

Suggestions include putting petroleum jelly around the nostrils to trap pollen and showering and changing clothes after going outside to wash off pollen. People with mild hay fever symptoms can buy medications like antihistamine tablets, eye drops, or nasal sprays from a pharmacy or other stores to help relieve symptoms.

If that doesn’t work, local community pharmacists will be able to provide advice and guidance on a wider range of medicines previously only available by prescription. Hay fever is a common allergic reaction in which our body reacts to pollen in the air during spring and summer.

When pollen enters your body, your immune system sees it as an invader and begins to react to attack it. The body’s response releases a chemical called histamine, which widens blood vessels and triggers allergy symptoms like a stuffy nose or watery, itchy eyes.

Some people start having hay fever as early as February and it can affect them until September.

READ MORE: Changes at Somerset Hospital could force patients to seek treatment elsewhere

What causes hay fever and what are the symptoms?

In the UK, hay fever is mainly triggered by pollen from trees, grasses and weeds, as well as mold in the environment. The timing of your symptoms should give you an idea of ​​the type of pollen you are reacting to.

If your symptoms worsen between February and June, you are probably reacting to tree pollen. Those with a May-July reaction are likely triggered by grass pollen, which is the most common cause of hay fever.

People with hay fever symptoms from June to September react to weed pollen.

Common symptoms of hay fever include:

  • To sneeze
  • Runny or stuffy nose
  • Watery and itchy eyes
  • Itchy mouth or tongue
  • Headache
  • Fatigue
  • Wheezing

What can you do to treat hay fever?

You can monitor pollen counts to try to avoid hay fever trigger spikes. Sufferers should check the weather forecast, minimize their exposure to pollen by wearing sunglasses and tying their hair back when outdoors as well as changing clothes when entering.

Balms can also be applied around the nostrils and eye sockets to help catch pollen before it is inhaled. Other remedies include nutritional and herbal alternatives like nettle tea, vitamin C, quercetin, bromelain, inhaling with a dry salt pipe 10-25 minutes daily, taking vitamin D and eating locally produced honey to build resistance to pollen – although there is no scientific evidence that it works.

You can also stay indoors as much as possible, close your windows, dry your clothes indoors, turn off fans, and make sure to vacuum and dust your home regularly.

read more
Medical supplies

Medicines and medical supplies donated by India handed over to Sri Lanka

*
Medicines and medical supplies donated by India handed over to Sri Lanka

Friday, April 29, 2022, 7:37 p.m. SL time, ColomboPage News Desk, Sri Lanka.

April 29, Colombo: Indian High Commissioner Gopal Baglay handed over a large consignment of medicines and other medical supplies to Professor Channa Jayasumana, Minister of Health in Colombo on April 29, 2022.

The Indian Navy vessel “INS Gharial”, specially deployed to ensure the prompt delivery of the medical consignment, a gift from the people of India, arrived at the port of Colombo today.

These medical supplies meet the demand of Peradeniya Teaching Hospital, the Indian High Commission in Colombo said. The shortage of essential supplies at the teaching hospital was noted by the Minister of External Affairs, Dr. S. Jaishankar, during his visit to Sri Lanka in March 2022.

Other medical shipments in response to specific requests from various medical entities operating in all parts of Sri Lanka are also scheduled from India. In addition, $200 million has been earmarked for the provision of medical supplies under the $1 billion line of credit for essentials such as food, medicine, etc.

India has recently extended rapid support to Sri Lanka. The overall economic aid, which amounts to nearly $3 billion in 2022 alone, has been of various kinds – a $1 billion line of credit for essentials; Line of credit of 500 million USD for the purchase of petroleum products; bilateral currency exchange of $400 million; and over $1 billion under the Asian Clearing Union Framework. The USD 1 billion line of credit is operational and 16,000 tons of rice have already arrived in Sri Lanka, among other items, under this line of credit.

read more
Prescription drugs

Where to Dispose of Prescription Drugs in WNY on National Prescription Drug Take Back Day

BUFFALO, NY (WKBW) — The Drug Enforcement Administration will hold its National Prescription Drug Take-Back Day on Saturday, which aims to prevent addiction and reduce overdose deaths.

“National Prescription Drug Take-Away Day aims to provide a safe, convenient, and responsible way to get rid of prescription drugs, while educating the general public about the potential for drug abuse,” its website states.

Below 7 News has compiled a list of places in Western New York where law enforcement hosts sites where you can dispose of prescription drugs on Saturdays from 10 a.m. to 2 p.m.:

  • Tonawanda Police Department, Kenmore Mercy Hospital – 2950 Elmwood Avenue, Kenmore
  • Cheektawaga Police Department, Cheektawaga Senior Center – 3349 Broadway, Buffalo
  • Hamburg Police Department, Wegmans – 3740 McKinley Parkway, Blasdell
  • West Seneca Police Department, Wegmans – 651 Dick Road, Cheektowaga
  • West Seneca Police Department, West Seneca Senior Center – 4620 Seneca St., West Seneca
  • North Tonawanda Police Department, DeGraff Memorial Hospital – 445 Tremont St., North Tonawanda
  • Amherst Police Department, Millard Fillmore Hospital – 1540 Maple Road, Amherst
  • Hamburg Police Department, Hamburg Senior Center – 4540 Southwestern Boulevard, Hamburg
  • Lancaster Police Department, Twin District Fire Department – 4999 William Street, Lancaster
  • Niagara County Sheriff’s Office, Mt. St. Mary’s Hospital – 5300 Military Road, Lewiston
  • North Collins Police Department, North Collins Police Department – 10543 Main Street, North Collins
  • Erie County Sheriff’s Office, Elma Town Hall – 1600 Bowen Road, Elma
  • Genesee County Sheriff’s Office, Pembroke Town Hall – 1145 Main Road, Corfu
  • Wyoming County Sheriff’s Department, Attica Police Department – 43 Exchange Street, Attica
  • Batavia Police Department, Batavia Police Department – Alva Place Parking Lot, Batavia Downtown Shopping Mall, Batavia
  • Cattaraugus County Sheriff’s Office, Salamanca Municipal Building Fire Department – 225 Wildwood Avenue, Salamanca
  • Cattaraugus County Sheriff’s Office, Delevan Plaza – 40 N. Main Street, Delevan
  • Chautauqua County Sheriff’s Office, Alstar North Headquarters – 738 Monroe Street, Dunkirk
  • Wyoming County Sheriff’s Office, Wyoming County Sheriff’s Office – 151 N. Main Street, Warsaw
  • Roy Police Department, Roy Police Department – 3 Main Street West, Le Roy
  • Orleans County Sheriff’s Office, Public Safety Building – 13925 State Route 31, Albion
  • Wyoming County Sheriff’s Office, Perry Police Department – 46 North Main Street, Perry
  • Chautauqua County Sheriff’s Department, Old Five Star Bank – 284 East Fairmount Avenue, Lakewood
  • Warren County Sheriff’s Office, Warren County Sheriff’s Office – 407 Market Street, Warren, PA
  • Westfield Police Department, Westfield Family Doctors – 138 E. Main Street, Westfield
  • Olean Police Department, Olean Police Department, 101 E. State Street, Olean
  • Youngsville Borough Police Department, Youngsville Borough Police Department – 40 Railroad Street, Youngsville, Pennsylvania
  • Allegany County Sheriff’s Office, Canaserega Fire Department – 10 Main St., Canaseraga
  • Allegany County Sheriff’s Office, YMCA – 133 Bolivar Road, Wellsville
  • Wesleyville Borough Police Department, Wesleyville Borough Police Department – 3421 Buffalo Road, Erie, PA
  • Erie Police Office, Main Municipal Building for the City of Erie – 626 State Street, Erie, PA
  • Millcreek Township Police Department, Millcreek Township Police Department – 3608 West 26th Street Erie, PA

You can find more information on the DEA’s website here.

read more
Generic drugs

Global Generic Drugs Market Growing at a CAGR of 7% During 2022-2027 – Ripon College Days

The latest research report from the IMARC group, titled “Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.

The global generic drug market reached a value of US$320 billion in 2021. Looking ahead, IMARC Group expects the market to reach US$482.5 billion by 2027exposing to a CAGR of 7% during 2022-2027. A generic drug is an off-patent drug that is identical to other brand name drugs in terms of effect, form, dosage, intended use, quality, and safety. These drugs can only be manufactured after the brand name drug’s patent has expired. Compared to other branded drugs, these are cheaper and do not require extensive research and testing.

Get a free sample copy of the report at – https://www.imarcgroup.com/generic-drug-manufacturing-plant/requestsample

Important Attribute and Report Highlights:

  • Detailed Global Market Share Analysis
  • Market segmentation by therapeutic area, drug delivery and distribution channel.
  • Historical, current and projected market size in terms of volume and value
  • Latest industry trends and developments
  • Competitive landscape for the generic drugs market
  • Strategies of key players and product offerings

Global generic drug industry trends:

The global market is mainly driven by the increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, Alzheimer’s disease and Parkinson’s disease. Additionally, significant growth in the pharmaceutical industry has boosted the growth of the market across the globe. Apart from this, increased expenditure by the government as well as private companies to manufacture generic drugs that can improve the healthcare system has created a positive outlook for the market. Additionally, the growing geriatric population has positively influenced the growth of the market. Additionally, the upcoming patent expiration of many branded drugs is expected to drive the market towards growth.

Main generic drug companies in the world:

  • Teva Pharmaceuticals Industries Ltd.
  • Mylan AG
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Fresenius SE & Co.
  • Lupine Limited
  • Endo Pharmaceuticals Inc.
  • Aurobindo Pharma Limited
  • Aspen Pharmacare Holdings Limited

Do you know more information, contact our analyst at– https://bit.ly/3Or8H3T

Overview of the impact of COVID-19:

We regularly monitor the direct effect of COVID-19[feminine] in the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.

Key Market Segmentation:

Breakdown by therapeutic area:

  • Central nervous system
  • Cardiovascular
  • Dermatology
  • Genitourinary/Hormonal
  • Respiratory
  • Rheumatology
  • Diabetes
  • Oncology
  • Others

Rupture by administration of drugs:

  • Oral
  • Injectables
  • Dermal/Topical
  • Inhalers

Breakdown by distribution channel:

  • Retail pharmacies
  • Hospital pharmacies

Breakdown by region:

  • North America (USA, Canada)
  • Asia-Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

Table of Contents of Generic Drugs Market Research Report:

  • Preface
  • Scope and methodology
  • Summary
  • Introduction
  • Global Generic Drugs Market
  • SWOT analysis
  • Value chain analysis
  • Price analysis
  • Competitive landscape

Who we are:

The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.

IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.

Contact us:

IMARC Group

30 N Gould St, Ste R

Sheridan, WY (Wyoming) 82801 United States

Email: [email protected]

Such. :(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

read more
Medical products

Allied Corp. enters into a sales agreement with a Brazilian distributor of medical products

Canadian cannabis producer Allied company. (OTCQB: ALID) added another list of sales contract recipients for its BC-grown pot.

On Wednesday, the Kelowna-based company announced that under the purchase agreement, US$147,000 of its products would go each month to an unnamed Brazilian distributor who would deliver medical products to Israelita Albert Einstein Hospital in São Paulo.

Cannabis products are intended for thousands of Brazilians undergoing cancer treatment. The sales agreement took four months to approve due to product review, manufacturing specifications and testing.

The company plans to send the first monthly shipments under the contract starting in May this year.

Shares of the company fell 8.3% on Wednesday to US$0.78 on the OTC market.

Albert Einstein Hospital in São Paulo. Photo by Lukaaz–Marcelo via Wikimedia Commons

Read more: Allied Corp. exports dried flowers grown in Colombia to Australia and the United States

Read more: Allied Corp. will send 1 million euros worth of cannabis to its Australian partner

The Israelita Albert Einstein Hospital in São Paulo was founded in 1971 with the mission of providing quality health care, generating knowledge and promoting social responsibility. He specializes in providing complex treatments in oncology and neurology.

According to Forbes, it is among the top 20 hospitals in the world.

The hospital’s research and education institute has already trained around 130,000 professionals and conducts hundreds of studies each year.

Allied’s products will be offered specifically to patients undergoing cancer and neurological treatments.

“With over 200 million people, Brazil is an obvious market for us at Allied. Quality, flavor profiles and supply chain integrity were all considered in bringing the Brazilian partner and Allied together under this agreement,” said Allied CEO Calum. Hughes, in a statement.

“The rigorous review process that Allied underwent in order to meet the standard for a customer of this caliber again demonstrates our manufacturing competence and knowledge of international regulatory compliance,” he said, adding that the revenue this generates will only fuel their future growth. .

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Natalia Buendia Calvillo on Twitter

[email protected]

read more
Medical products

Veress Needle Market Size, Scope and Outlook

New Jersey, United States – The study is a professional and comprehensive assessment of the Veress needle market with an emphasis on in-depth analysis of market data. The purpose of the study is to provide a quick understanding of the business along with a comprehensive categorization of the Veress Needles market by type, activity, end-use, and region. The study provides specific market statistics for major manufacturers and distributors, as well as an analysis of the outlook for the industry in general. The study examines the global Veress Needles market by considering supply and demand and identifies the variables that will influence the Veress Needles market in each region during the projection period. On the consumer side, market trends, limitations and opportunities as well as an assessment of consumer development are examined.

The study discusses the elements driving the global Veress needles market. Traders and investors can use this data to strategize to increase their market share, and newcomers can use it to locate opportunities and grow in the business. There are also some restrictions on expanding this market. The Veress Needle Market study also provides company biographies, SWOT analysis and business strategies for key industry players. Additionally, the research focuses on major industry players, providing details such as company descriptions, skills, current finances, and company advancements.

Get Sample Full PDF Copy of Report: (Including Full Table of Contents, List of Tables and Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=212073

Key Players Mentioned in the Veress Needle Market Research Report:

CONMED, Fairmont Medical Products Pty Ltd, GRI-Alleset, Grena Ltd., 3-Dmed, Advin Health Care, Changzhou Ankang Medical Instruments Co., Ltd., Duomed Group, Endomed Systems GmbH, Zhejiang Geyi Medical Instrument Co., Ltd. , LOCAMED LIMITED.

Market factors could use prospect information to attract informed prospects in underdeveloped countries. The analysis covers sales, revenue, annual growth and market share of Veress Needle in the global market for the past and future years. Figures for the past year and subsequent years show the sales, revenue, growth rate and customer base of each industry. Veress Needle Market Research has published a report that examines the key physical and chemical growth methodologies employed by companies in the Veress Needle market. Product launches, product endorsements, and intellectual property strategies were among the most common tactics for sustained growth. Partnerships, collaborations and alliances were among the most important tactics for business expansion. Veress Needle Market participants were able to increase their business through these actions.

Segmentation of the Veress needle market:

Veress Needles Market, By Type

• 120mm
• 150mm
• Others

Veress Needles Market, By Application

• Gynecological surgery
• Urological surgery
• General surgery

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=212073

Scope of the Veress Needles Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

Determining the pulse of the market becomes easy with this detailed analysis of the Veress Needle market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the Veress Needle market?

2. How will the Veress needle market evolve over the next five years?

3. Which product and application will occupy the lion’s share of the Veress needle market?

4. What are the drivers and restraints of the Veress Needle Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Veress Needle market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/veress-needle-market/

Visualize the Veress Needle Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and findings with an integrated presentation feature that saves you over 70% of your time and resources for presentations to investors, sales and marketing, R&D and development of products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Veress needle market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical supplies

Americares sends 100 tons of medical supplies to Ukraine

[Image courtesy of Americares]

Americares announced this week that it will deliver 100 tons of much-needed medicine and medical supplies to Ukraine.

The health-focused relief and development organization based in Stamford, Conn., said the shipment would support health care providers treating children and adults affected by the humanitarian crisis in Ukraine. Supplies include antibiotics, medication for conditions such as diabetes and hypertension, wound care products, and first aid and hygiene supplies.

“The needs in Ukraine, as well as in Poland and other neighboring countries where millions of refugees have fled, are enormous,” said Americares Director of Complex Humanitarian Emergencies Adam Keehn. “We are committed to meeting these short and long-term needs, with the medicines and relief supplies we have already provided making a vital difference for those caught in the crisis.”

To date, Americares has shipped more than 40 tons of emergency aid and 65 tons are due to leave its global distribution center over the next 30 days. The organization also provided nearly $600,000 in emergency funding to 25 organizations working in Poland, Romania and Ukraine.

In addition to more than 500,000 prescription drugs and 100,000 urgently needed medical supplies, the organization is sending 17,000 liters of IV fluids and other life-saving items to healthcare facilities in Ukraine. The supplies will be distributed to more than 20 partner organizations, according to Americares.

Several medical device companies have donated supplies to Americares and other humanitarian organizations since February to support Ukraine’s relief efforts following the Russian invasion. The World Health Organization has delivered around 300 tonnes of medical supplies to support the worst affected areas in the region, including a recent delivery of 78 tonnes of drugs and intravenous fluids for emergency medical care, medicines trauma and surgical essentials and supplies. , according to the WHO external status report.

read more
Medical supplies

Disposable Medical Supplies Consumption Market Size, Share, Growth 2022-2029 | Key Players – Johnson & Johnson, Baxter, Fresenius, Boston Scientific

New Jersey, United States,- The global Disposable Medical Supplies Consumption Market is examined extensively and thoroughly in the report, focusing on the competitive landscape, regional growth, market segmentation, and market dynamics. For the preparation of this in-depth research study, we used the latest primary and secondary research techniques. The report provides Porter’s Five Forces Analysis, Pusher Analysis, Competition Analysis, Manufacturing Cost Analysis, Sales and Production Analysis and various other types of analysis for To provide a comprehensive overview of the global disposable medical supplies consumption market. Each segment of the global Disposable Medical Supplies Consumption market is carefully analyzed on the basis of market share, CAGR, and other significant factors. The global disposable medical supplies consumption market is also presented statistically using annual growth, CAGR, sales, production, and other important calculations.

We can customize the report to your liking. Our analysts are experts in the study and analysis of the Disposable Medical Supplies consumption market and have extensive experience in customizing reports, having served tons of clients so far. The main purpose of preparing the research study is to educate you about the future challenges and opportunities in the market. The report is one of the best resources that you can use to secure yourself a strong position in the global consumer disposable medical supplies market.

Get | Download Sample Copy with TOC, Charts and List of Figures @ https://www.marketresearchintellect.com/download-sample/?rid=449886

Our report contains current and latest market trends, company market shares, market forecasts, competition benchmarking, competition mapping and an in-depth analysis of the most important sustainability tactics and their impact on market growth and competition. To estimate the quantitative aspects and to segment the global disposable medical supplies consumption market, we have used a recommended combination of top-down and bottom-up approaches. We have examined the global disposable medical supplies consumption market from three key angles through data triangulation. Our iterative and comprehensive research methodology helps us deliver the most accurate market forecasts and estimates with minimal errors.

Major Players Covered in Consumer Disposable Medical Supplies Markets:

  • Johnson & Johnson
  • Baxter
  • Fresenius
  • Scientific Boston
  • Medtronic
  • comics
  • 3M
  • Terumo Company
  • B. Braun
  • Blacksmith and nephew
  • Abbott
  • CR Bard
  • Novartis
  • ConvaTec
  • Medical line
  • Teleflex
  • Halyard Health
  • Nitto Medical
  • Coloplast
  • group of blacksmiths
  • Weigao
  • Medical BSN
  • Lohmann & Rauscher
  • Ansel

Disposable Medical Supplies Consumption Market Split By Type:

  • Injection and infusion
  • Wound care
  • Blood and dialysis
  • Medical implant equipment
  • Disposable clothing
  • Incontinence supplies
  • Surgical supplies

Disposable Medical Supplies Consumption Market Split By Application:

  • Home Health care and nursing home
  • Hospitals and other medical establishments
  • Others

As part of our quantitative analysis, we have provided regional market forecast by type and application, market forecast and sales estimate by type, application and region by 2030, and sales forecast and estimate and production for consumption of disposable medical supplies by 2030. Qualitative analysis, we focused on policy and regulatory scenarios, component benchmarking, technology landscape, important market topics along with the landscape and industry trends.

We also focused on technological advance, profitability, company size, company valuation against industry and product and application analysis against market growth and market share.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=449886

Scope of the Disposable Medical Supplies Consumption Market Report

Report attribute Details
Market size available for years 2022 – 2030
Base year considered 2021
Historical data 2018 – 2021
Forecast period 2022 – 2030
Quantitative units Revenue in USD Million and CAGR from 2022 to 2030
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Market Analysis The consumption of disposable medical supplies can be represented as follows:

This part of the report assesses key regional and country-level markets on the basis of market size by type and application, key players, and market forecast.

Based on geography, the global disposable medical supplies consumption market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-disposable-medical-supplies-consumption-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. Etc. Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Medical products

Benefits of medical products shares on April 28: TMO, BIO and more

The first quarter earnings season for the Medical sector started last week. The last Revenue overview reflects a strong year-over-year improvement in quarterly performance so far in this reporting cycle. According to the industry scorecard, 7% of companies in the medical sector, constituting nearly 27.6% of the sector’s market capitalization, reported profits through April 22. Of these, 100% beat earnings estimates and 75% beat the same for revenue. Profits rose 8.4% year over year on the back of revenue up 13.5%.

This dashboard reflects the current stability in the United States on the continued economic reopening. However, a number of MedTech players faced severe staff shortages and supply chain vagaries in the first quarter, thanks to the emergence of new COVID variants.

Overall, first-quarter medical profits are expected to rise 10.3% on a 13.3% increase in sales. That compares to reported earnings growth of 27.8% and revenue growth of 14.3% in the fourth quarter. It is worth mentioning that the medical sector is expected to be one of the nine sectors that are expected to register profit growth in the first quarter of 2022.

Quarterly summary of medical products

An integral part of the broader medical industry, Zacks’ definition Medical products Collective growth in business activity is expected to have improved compared to last year, with a significant increase in the vaccination campaign and a reduction in COVID-related deaths in the United States and other developed countries. The dynamic nature of the COVID-19 crisis has been a roller coaster ride for the medical products industry over the past few months.

In the recent past, companies in this space had experienced a sharp decline in their core business. However, results for the majority of medical product stocks have so far shown accelerated growth in non-COVID business in the first quarter months compared to 2020 on a reduction in the severity of COVID-19 despite the emergence new virus variants. Overall, the recovery of the companies’ legacy core business during the first quarter months was impressive. Medical product companies like Thermo Fisher Scientific OMT, Bio-Rad Laboratories ORGANIC, LabCorp HL and ResMed RMD is likely to have been impacted by these factors in the first quarter.

It should be mentioned here that disruptions in the form of the emergence of more contagious COVID-19 variants like Delta, Omicron and XE are still evident in many developed countries. A number of MedTech players faced severe staffing shortages and supply chain uncertainties during the first quarter months. As a result, many industry players have witnessed a decline in their business performance on a sequential basis.

In addition, first-quarter results from diagnostic testing companies showed lower demand for testing so far, due to declining cases, which has dampened business growth for many companies.

Let’s take a look at four Medical Products players who are due to announce their results on April 28th.

Thermo Fisher Scientific: During the first quarter months, Thermo Fisher’s analytical instruments segment should have generated strong sales thanks to the flourishing electron microscopy, chromatography and mass spectrometry businesses. The company is expected to record growth driven by a favorable business mix and a strong increase in volumes and productivity enabled by the PPI trading system. (Read more: Thermo Fisher to Release First Quarter Results: What’s in Store?)

Zacks’ consensus estimate for total revenue of $10.63 billion for the first quarter suggests a 7.3% increase over the reported figure for the year-ago quarter. The consensus mark for Thermo Fisher’s earnings of $6.17 per share indicates a decline of 14.4% from the reported figure for the year-ago quarter.

According to our proven model, a title with the combination of a positive effect ESP Earnings and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) has a good chance of beating the estimates. However, this is not the case as you can see below.

TMO has an ESP on earnings of -1.20% and carries a Zacks rank #3. You can discover the best stocks to buy or sell before they’re flagged with our Income ESP filter.

Thermo Fisher Scientific Inc. Prize and EPS Surprise

Thermo Fisher Scientific Inc. price-eps-surprise | Quote from Thermo Fisher Scientific Inc.

You can see the full list of today’s Zacks #1 Rank stocks here.

Bio-Rad Laboratories: Bio-Rad’s life sciences segment has seen robust revenue growth in recent quarters. We expect this growth momentum to continue in the first quarter thanks to continued sales growth in the Polymerase Chain Reaction (PCR), Droplet Digital PCR (dPCR), Process Media and Western Blot businesses. The company also saw strong growth in the biopharmaceutical market for the Droplet Digital PCR platform, which is expected to have made a significant contribution to first quarter revenue. (Read more: Bio-Rad to Report First Quarter Results: What’s in the Charts?)

Zacks’ consensus estimate for Bio-Rad’s first-quarter revenue is set at $678 million, implying a 6.7% decline from the prior year’s figure. The consensus estimate for earnings per share is set at $2.80, suggesting a decline of 46.3% from the figure reported the previous year.

BIO has a Gain ESP of 0.00% and a Zacks Rank #3.

BioRad Laboratories, Inc. EPS Awards and Surprise

BioRad Laboratories, Inc. EPS Awards and Surprise

BioRad Laboratories, Inc. price-eps-surprise | BioRad Laboratories, Inc. Quote

LabCorp: LabCorp recorded a continued rebound in sales in the core business for the Diagnostics and Drug Development segments. However, as the effects of the pandemic fade, we expect demand for COVID-19 testing services to gradually decline, which will impact first quarter sales performance. In the fourth quarter of 2021, the company reported higher adjusted operating income and improved margins within the core business, given organic growth and LaunchPad savings. According to the fourth quarter earnings call, the company has implemented a new LaunchPad business process improvement initiative, which is expected to generate $350 million in savings over the next three years. The new initiative is expected to have helped the company’s margin in the first quarter. (Read more: LabCorp to Report First Quarter Results: What’s in the Cards?)

Zacks’ consensus estimate for first-quarter earnings of $5.88 a share implies a 33.1% drop from the figure reported a year ago. The consensus revenue estimate is set at $4.04 billion, suggesting a 2.9% drop from the figure reported the previous year.

LH has an ESP on Earnings of -0.22% and a #3 Zacks Rank.

Laboratory Corporation of America Holdings award and EPS surprise

Laboratory Corporation of America Holdings award and EPS surprise

Laboratory Corporation of America Holdings price-eps-surprise | Quote from Laboratory Corporation of America Holdings

ResMed: ResMed is expected to have benefited in the third quarter of fiscal 2022 from increased demand for sleep and respiratory care devices thanks to the steady recovery of markets following the impacts of COVID-19 and the recall of products from a competitor. The growth of home medical equipment and home care facilities should have contributed to the revenue growth of the SaaS business. Continued robust adoption of ResMed’s AirSense 10 and AirSense 11 platforms reinforces optimism for the company. These developments likely contributed to the company’s revenue in the upcoming quarter.

Zacks consensus estimate for its fiscal third quarter earnings per share is set at $1.44. Revenue is expected to be $908.7 million.

RMD has an ESP of 0.00% and Zacks Rank #3.

ResMed Inc. Award and EPS Surprise

ResMed Inc. Award and EPS Surprise

ResMed Inc. price-eps-surprise | Quote ResMed Inc.

Stay up to date with upcoming results announcements with the Zacks Earnings Schedule.

Zacks names ‘only one best choice for doubling up’

From thousands of stocks, 5 Zacks experts have each picked their favorite to skyrocket by +100% or more in the coming months. Of these 5, Research Director Sheraz Mian selects one to have the most explosive advantage of all.

It’s a little-known chemical company that’s up 65% year-on-year, but still very cheap. With relentless demand, rising earnings estimates for 2022 and $1.5 billion for stock buybacks, retail investors could jump in at any moment.

This company could rival or surpass other recent Zacks stocks which are expected to double, such as Boston Beer Company which jumped +143.0% in just over 9 months and NVIDIA which jumped +175.9% in one. year.

Free: See our best stock and our 4 finalists >>

Click to get this free report

Laboratory Corporation of America Holdings (LH): Free Stock Analysis Report

Thermo Fisher Scientific Inc. (TMO): Free Inventory Analysis Report

ResMed Inc. (RMD): Free Stock Analysis Report

BioRad Laboratories, Inc. (BIO): Free Stock Analysis Report

To read this article on Zacks.com, click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

read more
Prescription drugs

Nursing home nurse gave residents with dementia non-prescription medication

A registered nurse has admitted giving dementia patients at a nursing home non-prescription drugs on her day off, after claiming they were violent, including one who bit and hit others.

Elisabeth Buckley has admitted to the professional misconduct charges, including forging another nurse’s signature to prescribe the drug.

Buckley appeared in the Health Practitioners Disciplinary Court on Wednesday after the charges were brought by a New Zealand Nursing Council Professional Conduct Committee.

Buckley worked as a facility manager at an Auckland nursing home for residents with dementia, between January 6, 2020 and March 16, 2020, when she resigned.

She was hired in response to a district health board audit which identified 29 unmet criteria and the need for the facility to be managed by a qualified person.

Buckley was responsible for closing unmet audit criteria, many of which were related to inadequate documentation and systems.

An agreed summary of facts stated on Saturday, January 11, Buckley instructed a health care assistant to give two patients Lorazepam, which was not prescribed.

When the assistant questioned the instructions, Buckley told her “I’m the registered nurse” and that she had already informed the doctor.

Buckley personally administered Lorazepam to a third patient.

She also admitted to forging the signature of the facility’s registered nurse on a patient’s food profile.

The court was convinced that Buckley’s actions constituted professional misconduct.

Buckley testified at a hearing to determine her sentence.

“I want to acknowledge that I take full responsibility for my actions,” she said.

“I acknowledge that my conduct was extremely unprofessional.”

Buckley claimed the drug was given to patients after she saw them show signs of ‘sunset’ behavior, which occurs in people with dementia who may become more confused, agitated or insecure. of them as the day progresses.

She said patients had become verbally and physically abusive towards staff and residents.

A patient was throwing objects at people and hitting and biting staff and other residents, she said.

Buckley, who was not registered for work that day, said the patients had become incredibly anxious and agitated, so she decided to give them the drugs out of concern.

“I recognize that it was not appropriate for me to make this assessment.”

Buckley, who suffers from anxiety and depression as well as ADHD, described her new role as stressful and admitted she may have been too sensitive to what was going on.

“I was really concerned and worried for the residents and felt I had to do something for them.

“I accept that my actions were inappropriate and out of place.”

Buckley admitted to copying the RN’s signature from an old food profile onto a new document, as required by the DHB audit, but continued to deny it was intentional or that she had it falsified.

Matthew McClelland QC, appearing for the CCP, disputed Buckley’s claim, saying she deliberately tried to copy the nurse’s signature.

Buckley responded by saying she didn’t remember signing the form.

“I don’t remember trying to make one signature look like another.”

McClelland argued that Buckley’s conduct was a significant departure from accepted professional standards.

“It is professional misconduct and it is conduct that brings the nursing profession into disrepute.”

He said aggravating factors, including that Buckley was acting outside his scope of practice, had to be taken into account when deciding on a penalty.

Although the conduct did not warrant deregistration or a period of suspension from practice, the CCP wanted Buckley to undertake and successfully complete a Nursing Council of New Zealand course of study relating to the dispensing of drugs.

She must also disclose the court’s decision to any employer before she begins work as a registered nurse for a period of 12 months and a restraining order must be imposed to express the court’s strong disapproval and concern over the conduct. of Buckley.

Belinda Johns, representing Buckley, argued the offense was at the low end and any penalties should be kept to a minimum.

While Buckley’s actions had lowered the standards of the profession and undermined public trust, they came from a place of honesty and good intentions, Johns said.

Buckley was attached to the nursing profession. She felt she still had a lot to offer and was looking for a second chance, Johns said.

It was agreed that conditions would be placed on Buckley’s certificate of practice, which currently held none.

The court retired to consider the sanction to be imposed on Buckley and is expected to conclude later today.

– by Leighton Keith, Open Justice

read more
Generic drugs

Orrin Hatch’s influence on intellectual property goes far beyond generic drugs

By Dani Kass (April 26, 2022, 10:33 p.m. EDT) — Orrin Hatch, the longtime Republican senator from Utah who died on Saturday, has his fingerprints all over the current intellectual property system, where for 42 years he has worked on laws ranging from the Hatch-Waxman Act for generic drugs to the anti-piracy Digital Millennium Copyright Act.

Hatch introduced or sponsored a series of bills, many of which were signed into law, which revamped patent, copyright, trademark, and trade secret rights. In particular, he defended brand-name pharmaceutical interests while facilitating the sale of generics and biosimilars, strengthened copyright protections for artists, and united a patchwork of state trade secret laws… .

Stay one step ahead

In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.

  • Access to case data in articles (numbers, filings, courts, nature of lawsuits, etc.)
  • Access to attached documents such as briefs, motions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and more!

TRY LAW360 FREE FOR SEVEN DAYS

read more
Medical supplies

“Live their best and healthiest life”: delivering medical supplies to remote islands of Kiribati – Kiribati

STORY HIGHLIGHTS

  • The Pacific island nation of Kiribati is scattered across 3.5 million square kilometers of ocean, making it one of the most difficult places on earth to coordinate the equitable delivery of medical services and supplies to its people. .

  • The World Bank, supported by the Australian government and other partners, is helping Kiribati strengthen the management of its pharmaceutical supply chain, ensuring that health workers can make the most of all available resources.

  • Improved planning, budgeting and supply systems are helping Kiribati manage its response to the COVID-19 pandemic and ensure that clinics and pharmacies, especially on outer islands, have sufficient supplies and of equipment.

It’s no exaggeration to say that pharmacist Moannara Benete literally holds one of the most important positions in the Pacific. Kiribati’s 33 islands are spread over some 3.5 million square kilometers of ocean, and as head of the pharmacy team at the Kiribati Ministry of Health and Medical Services, Moannara is focused on provision of medical supplies for all the inhabitants of his country; no matter where they live.

This was already a huge challenge before COVID-19, and the pandemic has only amplified these challenges. Medical supplies have been hard to come by and there have been significant delays in their arrival. This has led to an increase in orders for urgent medical supplies, which has driven up prices.

“Procuring medical supplies is an important part of most health care services,” says Moannara Benete, from her office in Tarawa, the capital of Kiribati. “Our goal is to improve the overall health of the population by procuring and purchasing quality, cost-effective medical supplies. A well-managed supply program supports economic and social development by keeping people as healthy as possible.

Take control of health service delivery

The World Bank supports Kiribati’s commitment to advancing Universal Health Coverage so that all I-Kiribati can access health services when they need them. A key part of this work is to help track development partner contributions to health programs, so that they are recognized as part of the integrated plans and budgets managed by the Department of Health and Medical Services. By doing so, the department is then able to make the most of all available resources, ensure it understands where support is coming from and when, and take control of health service delivery. in a more effective and holistic way.

While many can access health care when they need it on Kiribati’s main island of Tarawa, it is much more difficult to ensure clinics and pharmacies on the outer islands are stocked with sufficient supplies and equipment.

“I’m really happy with the progress made by the pharmacy team. We have limited resources, but we work well as a team and there’s a lot of enthusiasm for what we do,” says Moannara. “We are improving supply chain management, and now, for the first time, we also have a comprehensive national list of essential medical supplies – which includes medicines, equipment and consumables.”

“Health center staff are now using tablets to track what is coming in and going out. It really helped us develop a better picture of what we need and when we need it.

Improving supply chains

Moanara took up a position with the Department of Pharmacy of the Kiribati Ministry of Health and Medical Services in 2011 after earning a degree in pharmacy in Fiji. In 2019, she completed a Masters in Public Health from the University of Melbourne, Australia. She says her studies helped shape her vision for improving the healthcare system at home.

“It made me think that the pharmacy sector was more than just a curative department. I realized that it sits at the center of health service delivery in many ways – spanning the spectrum of preventive, curative, restorative and palliative care needs in this country,” says Moannara. “If we can get the supply chain and distribution in place, then everyone across the islands will benefit.”

Access to contraceptives

One area of ​​particular passion for Moannara is her team’s work on sexual and reproductive health.

“Sexual and reproductive health commodities have traditionally been hard to come by here in Kiribati. We have been dependent on support from development partners,” she explains. “And with the borders closing due to COVID-19, it became even harder for us to get enough and there was a shortage.

“Yet our the data shows us that the number of married women with access to contraceptives has increased over the past decade, so if we can make sure the supplies are on the shelves, we know people will use them.

Dr Jennifer Butler, Director for the Pacific and Representative of the United Nations Population Fund (UNFPA), which supports this sexual and reproductive health work, says that improving access to modern contraceptives and health medicines vital kindergarten is vital work.

“It’s about improving access to contraceptives, increasing the visibility of availability — so people know where to get contraceptives — and building more sustainable systems,” says Dr. Butler. “This is essential work with a strong focus on gender equality, human rights and prosperity for all; and is essential for achieving universal health coverage.

Live their best, healthiest life

Moannara believes ensuring equal access to health services is a big challenge for Kiribati, but one she and her team are ready to meet.

“Our pharmacy team is committed to building the capacity of our healthcare system. We are driven by opportunities to learn as we go, and we certainly learn a lot. Leadership and effective and transparent decision-making are also very important,” says Moannara.

“We want to make sure that everyone has the opportunity to live their best life in the best state of health; no matter who they are or where they live.

World Bank support to the Kiribati Ministry of Health and Medical Services is provided in part by Advanced Universal Health Coveragea multi-donor trust fund set up by Australia Department of Foreign Affairs and Trade in 2015 to support the strengthening of health financing and service delivery systems in countries in East Asia and the Pacific. Other partners include Gavi, the global fundand the Bill and Melinda Gates Foundation.

read more
Medical products

Personal Mobility Devices Market Size, Scope and Outlook

New Jersey, United States – The study is a professional and comprehensive assessment of the personal mobility device market with an emphasis on in-depth analysis of market data. The aim of the study is to provide a quick understanding of the business along with a comprehensive categorization of the Personal Mobility Devices market by type, activity, end-use, and region. The study provides specific market statistics for major manufacturers and distributors, as well as an analysis of the outlook for the industry in general. The study examines the global personal mobility device market considering supply and demand and identifies the variables that will influence the personal mobility device market in each region during the projection period. On the consumer side, market trends, limitations and opportunities as well as an assessment of consumer development are examined.

The study discusses the elements driving the global personal mobility device market. Traders and investors can use this data to strategize to increase their market share, and newcomers can use it to locate opportunities and grow in the business. There are also some restrictions on expanding this market. The Personal Mobility Devices market study also provides company biographies, SWOT analysis and business strategies for key industry players. Additionally, the research focuses on major industry players, providing details such as company descriptions, skills, current finances, and company advancements.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=37564

Key Players Mentioned in the Personal Mobility Devices Market Research Report:

NOVA Medical Products, Performance Health, Drive DeVilbiss Healthcare, Medline Industries Invacare Corporation, Carex Health Brands Kaye Products Rollz International, GF HEALTH PRODUCTS and Briggs Healthcare

Market factors could use prospect information to attract informed prospects in underdeveloped countries. The analysis covers sales, revenue, annual growth and market share of personal mobility devices in the global market for the past and future years. Figures for the past year and subsequent years show the sales, revenue, growth rate and customer base of each industry. Personal Mobility Devices Market research has published a report that examines the key physical and chemical growth methodologies employed by companies in the Personal Mobility Devices market. Product launches, product endorsements, and intellectual property strategies were among the most common tactics for sustained growth. Partnerships, collaborations and alliances were among the most important tactics for business expansion. Participants in the personal mobility device market have been able to increase their business due to these actions.

Personal Mobility Devices Market Segmentation:

Personal Mobility Devices Market, By Product

• Wheel chairs
• Scooters
• Walking aids

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=37564

Scope of the Personal Mobility Devices Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the Personal Mobility Devices market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the personal mobility device market?

2. How will the personal mobility device market evolve in the next five years?

3. Which products and applications will capture the lion’s share of the personal mobility device market?

4. What are the drivers and restraints of the Personal Mobility Devices Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Personal Mobility Devices market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/personal-mobility-devices-market/

Visualize the Personal Mobility Devices Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a comprehensive overview and global competitive landscape with respect to region, country, and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Personal Mobility Devices Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Prescription drugs

Oral prescription medications keep a person healthy with type 2 diabetes. | cook for today

If medications are not well managed, optimal health goals will not be achieved.

Photoby author.

The author is not responsible for any advice, treatment, diagnosis or any other information you may obtain through these articles. The food and nutrition articles are for informational purposes only. After reading articles, watching videos, or other content, we strongly encourage you to carefully review the information with your healthcare professional.

Type 2 diabetes is about taking care of yourself 24/7. It can be daunting when first taking oral medications and even worse with multiple prescriptions. But with reasonable thought, it is possible to get off to a good start.

Prescription medications require a fixed daily schedule and it’s easy to miss doses. Keeping records will allow a person with type 2 diabetes to become familiar with brand and generic names, doses, times and dates. Some medications must be taken on an empty stomach, while others require food to be digested properly. Keep track of doses and appointments using a desk or smartphone calendar. Pill boxes, kitchen timers, alarm clocks, and smartphone apps are examples of reminders.

Building a trusting relationship with a doctor and following their advice and orders is an absolute requirement to help achieve both short- and long-term health goals. Each person is assessed individually and treated specifically for their state of health.

Using the same pharmacy for prescription refills and new orders is beneficial for someone with diabetes. Knowing the pharmacy staff will make the individual more comfortable, making visits to the pharmacy more pleasant and efficient. Don’t feel comfortable taking prescription or over-the-counter medication to the pharmacy or to the doctor to clarify questions. Family members or close friends will provide support. Involve family and close friends, but follow your intuition if something doesn’t sound right.

The internet is a gold mine of information, but there is a price to pay for believing everything you read. It is not advisable to buy drugs on the Internet claiming to cure. Mixing a prescription with an alternative medicine is not a good idea without consulting your GP.

Skipping doses or abruptly stopping medication without telling your doctor could be harmful to your body. Side effects can occur if not properly weaned off. Breaking up and sharing drugs with another person is not an option. It may be prudent to halve medications, but only with a doctor’s prescription. Expiration dates are in place for a reason. Products beyond the specified date may not fulfill their purpose.

Store all original medicine containers in a cabinet away from high temperatures, direct sunlight and moisture and out of sight of visitors, children and pets for safety reasons.

Keep a record of phone numbers for family, neighbors, local taxi service, emergency (911), doctor, and pharmacy on the fridge and car. Also keep all numbers in the contact list of the smartphone.

Finally, have confidence in yourself and remember that this is only one of the first steps towards a new role. Trust that many health professionals will provide care and guidance to ensure your health is a success.

References:
American Association of Diabetes Educators, Cornell, S., Halstenson, C. & Miller, DK (2019). The Art and Science of Diabetes Self-Management Education Desk Reference (4th ed.). American Association of Diabetes Educators.

read more
Medical products

Life Wear Technologies donates over 62,000 units of supporting medical products to House of Ukraine

POMPANO BEACH, Florida–(BUSINESS WIRE)–Life Wear Technologies, a leading provider of private label and branded sports medicine products, is pleased to announce a charitable contribution to the House of Ukraine, Inc. a cultural museum in San Diego providing information to the public about the country of Ukraine.

The donation consisted of more than 62,000 medical product units including knee, ankle and wrist braces, back support, elastic bandages, heat, cold packs and more. Regularly reporting on cultural aspects of Ukraine including art, history, traditions and language, House of Ukraine is also currently accepting product donations including military supplies and aid kits to donate to local Ukrainians in kyiv and to refugees.

“As a mass producer in the first aid and pharmacy market, we didn’t hesitate to find a way to support Ukraine with the supplies we have,” said Bradley Waugh, president and CEO of the management of Life Wear Technologies. “We are grateful to be able to offer our products as a useful medical aid, and hope they will even bring a glimmer of relief to those in need.”

the House of Ukraine, Inc. is a member of the House of Pacific Relations International Cottages, Inc, (HPR), Balboa Park, San Diego, California, founded in 1935 and is a nonprofit community organization dedicated to fostering cooperation and understanding among national groups in United States .

Learn more about the House of Ukraine, as well as Life wear technologies can be found at their corresponding links.

About Life Wear Technologies:

Life Wear Technologies, LLC was established in 1974 as one of the first manufacturers of sports medicine products. The company began selling its products to athletic trainers, institutions, sporting goods retailers and professional teams throughout the US market.

After gaining notoriety as a leading sporting goods innovator, the company moved into the growing first aid and pharmacy market. In addition to health supports, Life Wear began manufacturing elastic bandages, athletic bands and eventually hot and cold therapy products to become the first single-source solution for private label sports medicine products.

Today, Life Wear Technologies, LLC is a leading supplier of private label and branded sports medicine products sold through the drug, food and mass merchant distribution chains.

read more
Generic drugs

Generic Drug Sales Market Size 2022-2029 | Key Players – Teva, Novartis – Sandoz, Mylan, Sun Pharmaceutical – Ripon College Days

New Jersey, United States,- The research study presented here is a very detailed and meticulous depiction of almost all major aspects of the global generic drug sales market. It digs deeper into market dynamics including growth drivers, challenges, restraints, trends, and opportunities. Market players can use research studies to strengthen their hold in the global Generic Drug Sales market by gaining insight into market competition, regional growth, Generic Drug Sales market segmentation and various cost structures. This report provides accurate market outlook with respect to annual average, market size by value and volume, and generic drug sales product market share. It also provides carefully calculated and verified market figures regarding but not limited to revenue, production, consumption, gross margin, and price.

As part of the global economic outlook, this report sheds light on the current and future market scenarios for Generic Drugs Sales Products to consider while planning business strategies. In addition, the manufacturer’s pricing strategy is analyzed, raw materials and other costs are analyzed in depth. The regional assessment of the global generic drug sales products market includes a wide range of assessments of major markets such as North America, Europe, China, India, and India. All segments, applications, products or geographical categories are analyzed on the basis of important factors, i.e. their number. Generic Drug Sales Products Market Share, Consumption, Revenue, Volume, Market Size and Average Pa.

Get | Download Sample Copy with TOC, Charts and List of Figures @ https://www.marketresearchintellect.com/download-sample/?rid=241964

Along with a scorecard of the vendor landscape and important company profiles, the competitive analysis in the Medical Disposables market provides an encyclopedic examination of the structure of the market. The company stock analysis included in the study helps the players to improve their business tactics and compete well with the major market players in the Medical Disposable industry. The force map prepared by our analysts allows you to have a quick view of the presence of several players in the global medical disposables market. The report also provides a footprint matrix of the major players in the global medical disposables market. It dives deep into the growth strategies, sales footprints, production footprints, product and application portfolios of big names in the medical disposable industry.

Key Players Covered in Generic Drug Sales Markets:

  • Suits you
  • Novartis-Sandoz
  • Mylan
  • Sun Pharmaceutical
  • aspen
  • Fresenius Kabi
  • Pfizer (Hospira)
  • Sanofi
  • Aurobindo
  • Lupine
  • At Dr. Reddy’s
  • Apotex
  • cipla
  • ENDO (By Pharmaceutical)
  • Arzneimittel Stadium
  • Krka Group
  • Nichi-Iko Pharmaceutical
  • valiant
  • Zydus Cadila
  • Hikma

Generic Drug Sales Market Split By Type:

  • Simple generic drugs
  • Super generic drugs
  • Biosimilars

Generic Drugs Sales Market Split By Application:

  • CNS
  • Cardiovascular
  • Genitourinary/hormonal drugs
  • Respiratory
  • Rheumatology
  • Diabetes
  • Oncology
  • Others

As part of our quantitative analysis, we have provided regional market forecast by type and application, market forecast and sales estimate by type, application and region by 2030, and sales forecast and estimate and production for generic drug sales by 2030. For the qualitative analysis, we focused on policy and regulatory scenarios, component benchmarking, technology landscape, important market topics as well as landscape and industry trends.

We also focused on technological advance, profitability, company size, company valuation against industry and product and application analysis against market growth and market share.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=241964

Scope of the Generic Drug Sales Market Report

Report attribute Details
Market size available for years 2022 – 2030
Base year considered 2021
Historical data 2018 – 2021
Forecast period 2022 – 2030
Quantitative units Revenue in USD Million and CAGR from 2022 to 2030
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Market Analysis Generic Drug Sales can be represented as follows:

This part of the report assesses key regional and country-level markets on the basis of market size by type and application, key players, and market forecast.

Based on geography, the global generic drug sales market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-generic-drugs-sales-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients across various industries and organizations with the aim of providing personalized and in-depth research studies.

Our advanced analytical research solutions, personalized advice and in-depth data analysis cover a range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverages . Etc

Our research studies help our clients make superior data-driven decisions, understand market forecasts, take advantage of future opportunities and maximize efficiency by working as a partner to deliver accurate and valuable insights without compromise.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Medical supplies

Raising funds for medical supplies through blood drives for Ukraine | Community News

Among the impacts of the devastating situation in Ukraine, the war has resulted in a severe shortage of blood bags and other vital blood collection supplies that are essential for the immediate care of patients in Ukraine.

The Blood Connection (TBC) joins Blood Centers of America (BCA) and Fresenius Kabi to raise funds to send much needed blood supplies to help the Ukrainian blood industry. The campaign goal is to raise at least $250,000 and Fresenius Kabi will match all eligible contributions on an individual basis up to that amount, with all proceeds used to purchase and deliver the transfusion items.

Fresenius Kabi will match these donations made between April 18, 2022 and June 30, 2022.

On March 10, a warehouse in Ukraine used by Fresenius Kabi was hit by an artillery strike, causing a powerful explosion and fire that destroyed all equipment inside the warehouse. These vital supplies are needed by the Ukrainians now more than ever, as they treat the wounded from Russian strikes and attacks.

An employee of Fresenius Kabi in Ukraine wrote a letter about the experience stating: “Some of our colleagues voluntarily joined the armed forces and territorial defence, some provide daily support to medical personnel in hospitals, some make deliveries of merchandise [blood supplies] crossing active combat zones at the risk of their lives and health”.

“We are committed to helping the people of Ukraine,” said Dean Gregory, President, Global Business Operations, Transfusion Medicine and Cell Therapies at Fresenius Kabi.

“In addition to our ongoing work donating medicine and supplies through humanitarian aid organizations, this initiative brings the American blood community together in support of Ukraine. Blood is an essential part of patient care. patients, and we are proud to support this important national campaign.”

“The war in Ukraine has resulted in great unnecessary suffering, including a severe shortage of blood bags and other blood collection supplies that are critical to the immediate care of patients in Ukraine,” said Bill Block, President and CEO of the management of BCA.

“Our hope is that the collaboration between BCA, ABC and Fresenius Kabi – and the contributions of generous people across America – will help bring relief to those in dire need.”

TBC is once again offering community blood donors the opportunity to double the impact of their blood donation.

At certain mobile blood drives, $10 will be donated per donor. These gifts will be doubled by Fresenius Kabi. Any organization interested in organizing a blood drive for this cause can call 864-255-5003.

“At The Blood Connection, like the rest of the world, we are saddened by the invasion of Ukraine and share our support for those affected. We recognize that members of our communities are looking for ways to help, so we are giving our donors the opportunity to help save lives here and in Ukraine,” said Delisa English, President and CEO of The Blood Connection. “Many of us feel helpless as we watch the war unfold on the news. That’s how we can help here at home.

Additionally, the BCA Foundation welcomes monetary contributions from anyone interested in supporting the campaign. To learn more about how to participate, please visit BloodSupplies4Ukraine.com.

In March, TBC offered donors the opportunity to donate to United Help Ukraine, a nonprofit that supports relief efforts on the ground in Ukraine.

More than 1,100 donors responded to the initiative, helping TBC donate more than $5,800 to the organization.

BCA is a national organization made up of more than fifty independent blood centers, committed to helping these centers supply blood to local hospitals.

Fresenius Kabi is an international distributor of medical supplies needed for infusions and transfusions, and the blood bag supplier of The Blood Connection.

To find participating blood drives or centers near you, go to thebloodconnection.org/ukraine. Appointments are encouraged and walk-ins are welcome.

read more
Medical supplies

Minnesota professor creates nonprofit to provide medical supplies to Ukrainians

ST. PAUL, Minnesota — Paul Gavrilyuk sleeps about four hours a night.

It’s a miracle he gets any sleep. This native of Ukraine and professor of theology at Saint Thomas University in Saint Paul works around the clock to help his native country, which he left in 1993, but where his family and friends still live there.

A friend is an academic colleague who picked up a military rifle to help defend towns and villages from fierce and relentless attacks by Russian forces who were ordered on February 24 to invade the country by Russian President Vladimir Putin .

Gavrilyuk’s friend is his age, 50, and he has four children. He serves in what Gavrilyuk calls a “sniper unit” of Ukrainian Civil Defense Volunteers.

The two professors often text each other and sometimes talk on the phone.

Hearing daily about the conflict, Gavrilyuk thinks of joining the fight himself. But he had a better idea. It’s less risky, which makes his wife, Eugenia, happy. And, a higher reward. Much higher, he thinks.

He builds on something he started in 2015 after the Russians invaded Ukraine to annex Crimea. He created an organization called “Rebuild Ukraine” to raise funds for much-needed supplies like tourniquets and prescription drugs and then deliver them to Ukrainian hospitals.

Although he continues to teach at St. Thomas, nearly every other moment of his watch is devoted to Rebuilding Ukraine. The organization’s logo features the letter “U” in blue, surrounding a yellow bird: a phoenix – a bird whose meaning in Greek mythology is “rising from the ashes”. Blue and yellow are the national colors of Ukraine.

“I measure my life in tourniquets,” Gavrilyuk, who is Eastern Orthodox, said in a March 30 interview with The Catholic Spirit, newspaper of the Archdiocese of St. Paul and Minneapolis. “We have the capacity to send about 5,000 tourniquets to Ukraine every week.”

Tourniquets are medical devices used to stop blood flow by compressing veins and arteries, often as an emergency measure to keep a person alive. During military conflicts, tourniquets are used in the field and may be the only way to prevent fatal blood loss.

“We basically asked ourselves the question: what product can we provide to maximize the chances of saving a life in Ukraine? ” he said. “We want to participate in God’s mission to save lives.

As soon as the Russians invaded Ukraine in February, Gavrilyuk’s organization stepped up to raise funds and deliver tourniquets and other supplies in anticipation of the violent military conflict that followed.

So far, Rebuild Ukraine has introduced 2,500 tourniquets in the country, and Gavrilyuk hopes the efforts will not only continue, but intensify.

“The hope is to send 10,000 more next month,” he said. “We are really talking about easily 1,000 injured (Ukrainians) per day. So that means if I had 7,000 tourniquets to pump around the country every week, I’d be a very happy man.

His organization has 100 volunteers who live and work in two major Ukrainian cities – including Kyiv – to distribute donated supplies to hospitals and to the front lines of battle. He has about 15 volunteers in the United States; some of them are in the Twin Cities.

Gavrilyuk is also working on manufacturing bulletproof vests that will be shipped overseas and delivered to Ukrainian civilian defenders. He also recently uncovered another source for these vests – police departments who have “decommissioned” bulletproof vests due to their age.

He began contacting the police and said the response was encouraging.

“I want to thank the police chiefs, especially in Wisconsin and Texas,” he said. “What I wrote was a crazy request: Could you supply decommissioned police vests to Ukraine? They immediately replied, ‘Absolutely, yes. It would be an honor, in fact, to do so.

Gavrilyuk also decided on a food that would help Ukrainians: beef jerky. Beef is abundant in Ukraine and neighboring countries, and jerky is highly nutritious and easily transportable, he said.

Volunteers were already hard at work making it and distributing it to civilians and military.

He described one volunteer in particular – a woman who lives in Ukraine but is far from current military combat zones.

This volunteer is “drying meat in her house (and) is also sheltering 20 refugees”, he said. “And, her young husband, 25, is fighting (against the Russians). So the husband is fighting, the wife is looking after 20 refugees and producing over a hundred pounds a week of jerky for us.

He works hard to solicit donations for Rebuild Ukraine by traveling to other cities such as Chicago and New York and creating a website: restart-ua.org.

Compassionate action is Ukraine Rebuild’s raison d’être, he said.

“There is no endgame to what Putin is doing,” he said. “The Ukrainians are paying with the lives of civilians and the lives of its military and volunteer defense units. And, it’s awful. It is a very high price. And I think it’s important that the world not only admire Ukrainian bravery, but also support it with prayer and compassionate action.

Gavrilyuk’s wife was born in Russia, but she feels the same way about Putin’s attempt to take over Ukraine as a husband.

“When all these disasters started happening, not only me, (but) all of my Russian-born Russian friends who identify as Russian, felt the same, almost physical, feeling of nausea and disgust,” he said. said Eugenia, 57, a resident of Moscow. native who, like her husband, teaches in the theology department of the University of Saint-Thomas.

“It is harmful, as if you were poisoned. It’s a feeling of deep shame,” she added.

Rebuild Ukraine is above all her husband’s business, Eugenia fully supports him.

The war in Ukraine “is very difficult for me,” said Paul Gavrilyuk. “My elderly parents are now refugees. My great-aunt, who is 98… is a refugee (now living) in Lithuania.

For him, the balance sheet of the Russian invasion is simple.

“They are bombing civilians,” he said. “These are serious war crimes. … It’s ruthless and it’s a genocide of the whole culture.

– – –

Hrbacek is a photographer/reporter at The Catholic Spirit, the newspaper of the Archdiocese of St. Paul and Minneapolis.

read more
Medical supplies

How Minnesota can help Ukrainians short on medical supplies

Last week we saw a video of Mark J. Lindquist from Minnesota (motivational speaker, former political candidate and US Air Force veteran) talk about the humanitarian work he and many other American and world citizens are doing to help Ukraine during the war.

Now he says they need your help, and here’s how to do it.

Mark Lindquist with Володимир Михалишин.

Mark Lindquist with Володимир Михалишин.

What is it like in Ukraine right now?

This week, we spoke to him live as he tried to find a car to make humanitarian aid deliveries to Lviv, an area of ​​Ukraine that has been at the center of recent Russian missile attacks.

It gives us the mood of people (super plain) and what happens to be feared during his missions inside Ukraine, and he tells us how we can help Ukrainians with our money or with medical items.

More on that in a moment, but first, click PLAY to hear the conversation from this morning’s show. (Click here for unedited automatic transcription)

The issue of fear

James- So now that you’re here and doing the supporting work, is it okay, quite honestly, is it scary to come in now that you know the Russians are focusing on Lavi?

To mark – Let me put it to you this way. Fear or doubt or anxiety about missile attacks or bombings. We really don’t think about it often. Why? ‘Cause it’s something you can’t control, right?

If you get hit by a missile, you won’t know it, what do you hear about the people at the table? They exploded in Afghanistan. They didn’t remember anything. The first thing they remember is when they woke up in the hospital bed. To the right?

So you won’t know James. I’m not trying to be flippant or try to downplay the danger because it’s a war zone, but why spend your time caring? Because you won’t even know what happened, will you?

So you might as well focus your energy and your, your thoughts on what you can do to help and, and the Ukrainians in front of you. And now that doesn’t mean we’re crazy cowboys and take extra risks. No, but it’s just, no, it’s not fruitful to think about it.

Do what you can, with what you have, wherever you are. I don’t know who said it first, but Mark and so many other American veterans join with all kinds of civilians from the United States and many other countries, trying to do what they can for the people Ukrainian.

How can you contribute to the humanitarian effort?

Ukraine: Humanitarian aid to refugees (GoFundMe link)

CLICK FOR LINK
CLICK FOR LINK

Money is always good. This way they can buy local and that means helping the Ukrainian economy. Click HERE.

Medical items

Mark describes the needs very well here.

There are also items that can be posted that are non-medical.

TO SEND ITEMS ON THE LISTS BELOW:
Marc Lindquist
ul.Mickiewicza 23
37-700 Przemysl, Poland

Attachment-Wish List Ukraine 01

attachment-Ukraine Wish List 02

As always, if you have a comment, complaint, or concern about anything I’ve written here, please let me know: [email protected]

Last week’s video –

And the baskets he talked about in the video come to life.

Minnesota Beyond Humanitarian Aid – Delivering Easter Baskets to Ukrainians

We’ve followed Mark J. Lindquist’s journey, but it’s not just Mark there…there are so many people all working together. If you want to help them with money, it will help them buy the items people need locally so their economy won’t falter.

Click play to listen to the Y-105FM Early Morning Show Radio-On-Demand podcast!

Listen on demand with the Y105FM appand on the following podcast platforms: Apple podcast | Google Podcasts | Spotify

History is always made, but… do you remember our military history?

There are LOTS of interesting historical details here…

WATCH: 100 years of American military history

read more
Prescription drugs

Safely dispose of prescription drugs at Aberdeen Police Station on April 30

Submitted by Grays Harbor County Health

Ja Harbor Strong Coalition will be holding a prescription drug take-back event from 10 a.m. to 2 p.m. on Saturday April 30 at the Aberdeen Police Department at 210 E. Market St. in Aberdeen.

At the event, the public can dispose of unused or expired prescription drugs safely and easily. Both prescription and over-the-counter medications will be accepted. Medications can remain in their original container and labels do not need to be removed. Medications that are not in their original container will also be accepted.

The recovery event supports the Washington State Health Care Authority’s “Starts with One” campaign. The Starts with One campaign informs and educates young adults, their parents and seniors about the dangers of prescription drug abuse and the importance of safe storage and disposal of prescription opioids.

According to the campaign’s website, “75% of opioid abuse begins with people using drugs that weren’t prescribed to them – usually taken by a friend or family member.” Simple measures, such as the safe disposal of medications, can prevent them from being misused.

Attending these recovery events is something individuals can do to help fight the opioid epidemic and protect their loved ones. The Harbor Strong Coalition and Aberdeen Police Volunteers in Policing Services (VIPS) will be handing out free medicine boxes at this event.

Check out Harbor Strong’s Drug Take-Back event Facebook page for more information: https://fb.me/e/1qIB5KLhL

read more
Prescription drugs

The cost of prescription drugs in the United States is “inadmissible”

President Joe Biden visited Green River College in Washington on Friday to discuss cutting costs for American families, particularly for needed medications and treatments.


What do you want to know

  • President Joe Biden visited Green River College in Washington on Friday to discuss cutting costs for American families, especially for prescription drugs
  • Biden has long advocated putting a $35 monthly cap on the price of insulin and included the provision in his original Build Back Better bill, which all but died in the Senate.
  • Insulin typically costs ten times more in the United States than in any other developed country, according to the Mayo Clinic, even though formulas for the drug haven’t changed in decades.
  • The US House of Representatives passed a bill capping the monthly cost of insulin at $35 for insured patients in early April, but it’s unclear whether the bill will pass the Senate.

The chair was introduced by Elisa Graceffo and her daughter, Juliana Graceffo, a senior from Eastlake High School who was diagnosed with type 1 diabetes at just four years old.

“When I was four years old, the treatment for type 1 diabetes consisted of 10 or more blood tests a day and 10 to 15 insulin injections a day with regular syringes,” young Graceffo said. “Today, I wear a continuous glucometer on my skin that tests my blood sugar level every five minutes, and that data is wirelessly transferred to my insulin pump.”

While Graceffo said she was grateful for medical advances and advocacy from individuals like President Joe Biden and Washington Sens. Maria Cantwell and Patty Murray, she highlighted the need to reduce the cost of insulin.

“We have better ways to dose and deliver the required insulin, but we still need the insulin itself,” she said. “And here, for my 14 years and counting as a diabetic, we haven’t seen anything but go up after the cost of insulin has gone up.”

It was a message that Biden later expanded on in his own speech, saying it was “unconscionable” that drugs cost more in the United States than in other developed countries.

“Let’s do something that will lower prices, lower the cost of prescription drugs,” Biden said, later adding, “Imagine what it’s like if you don’t have insurance, you don’t have watch your child know what he needs and know that there is nothing you can do about it. Not only is your child put in danger, but you are deprived of your dignity.

Insulin typically costs ten times more in the United States than in any other developed country, according to the Mayo Clinic. With more than 37 million Americans living with diabetes, it is now considered the costliest chronic disease in the United States.

The price of analog insulin – used to help the body convert glucose into energy – has “inexplicably” skyrocketed over the past two decades, according to the clinic, from an average price of $21 in 1999 to $332 in 2019.

The formula of the most commonly used versions of the drug has not been changed for more than 20 years.

“We’re not asking pharmaceutical companies to do anything they can’t afford,” the president said on Friday. “Do you think it doesn’t affect you?” It does. Everyone has less money in their pockets today because of the high cost of health care.

According to a 2019 Kaiser Family Foundation study, 24% of adults and 23% of seniors said it was “difficult” to pay for their prescription drugs. The same poll found that 79% of Americans say drug costs are “unreasonable” in the United States.

Biden has long advocated putting a $35 monthly cap on the price of insulin and included the provision in his original Build Back Better bill, which all but died in the Senate.

Although there was little to no discussion of reviving massive social spending and the climate plan as it was first presented, the United States House of Representatives passed in early April a bill capping the monthly cost of insulin at $35 for insured patients. It’s unclear whether the Senate has enough Republican support to pass the measure, and several senators are working on a different version of the proposal.

The president also wants companies that raise prescription drug prices faster than the rate of inflation to face a steep excise tax, saying Friday: “Let’s end the days when companies could raise prices. price without supervision or liability.”

Biden would also allow Medicare to negotiate the price of prescription drugs directly with drug companies in hopes of lowering costs for millions of Americans. Currently, Medicare can negotiate lower prices on almost all medical items except prescription drugs.

Another change to the Medicare system would impact seniors by capping the amount they must pay for prescription drugs at $2,000 per year.

The Associated Press contributed to this report.

read more
Prescription drugs

Belfast teenager changes his life after hitting rock bottom with prescription drugs and alcohol

A teenager who once attempted suicide is now leading mental health awareness seminars at local schools.

Gerard Mullan, from the Whitewell Road area of ​​north Belfast, sought refuge through prescription drugs and alcohol after his grandmother died.

Growing up without a father figure, Gerard’s world crumbled around him after the death of the man he admired – a catalyst for years of self-destruction.

Read more: Mom Ardoyne’s fresh start as she reaches 15 months sobriety

Speaking to Belfast Live about his journey, the 19-year-old opened up about his lowest point which left him in hospital and learning to walk on crutches.

“I’ve always had mental health issues, but after my grandmother died it impacted everything,” he said.

“He replaced the father figure that I didn’t have. He died when he was 99, and in my eyes he was never going to die. When he did, it just broke me. It broke everyone in my family.

“From there I just went a little crazy. I started rebelling, venting my anger on everyone. Then I turned to drugs, thinking it was a good idea at the time. I ruined everything between me and my family.

“I tried to hide everything from my mum, but when she found out, it broke everything.

“I started with prescription drugs, painkillers. Then it moved on to cannabis, then cocaine.

“At the time, I thought the drugs were helping me, but I was falling deeper and deeper into them and it was making me worse. Things got a bit over the top when I couldn’t get or finance the drugs.

“I was drinking more and more. Partying all the time – just being destructive. Mum and I would have been best friends, way more than mother and son. We were so strong and it just pushed that away. I I also lost friendships.

“It left me all alone.”

Gérard says that at some point he would have stayed in his house and closed himself off to the outside world.

Three years ago, he hit rock bottom.



Gerard Mulan

He added: “It’s hard for me today to think back to that moment in my life. I didn’t live for anything, I just lived to die. It’s hard for me to even say it.

“About a week before my seventeenth birthday, I went to my friend’s house and had an early drink that day. That’s when I knew what I was going to do. I ended up taking drugs and fighting with most people there.

“I tried to kill myself that night. When I was taken to the hospital, they didn’t know how I was still alive because I was losing a lot of blood because I had a wound in my stomach. head. It was bad.

“When I got to the hospital they put me in intensive care where I spent over a week. I was not allowed to leave until I could walk again, I So I had to learn to walk with crutches, which was difficult.

“I was dealing with a lot of things, it was a turning point for me. It scared me. Now I see that I was given a second chance in life. I went from there, to tell my story to others. I never thought I would see past 17.

“It took me a long time to accept my story and open up, but I know it can help others, so I’m owning my story now and learning more about myself. I have I’ve had offers to go to schools to talk about mental health and I’ve had great feedback.”

Gerard never thought he would see himself with a positive future.



Gerard Mulan
Gerard Mulan

Now he makes videos on social media, raising awareness about mental health, and his TikTok videos reach thousands of people. He is also creating his own podcast, where he wants to provide a platform for others to talk in an open environment.

He says talking openly about his darkest days can help someone come out of theirs.

“Even on a bad day now, I can turn it into a good day. My mental health today is good,” he said.

“I help people every day, and it gives me a sense of hope. If I could give one piece of advice, it would be to never get in the way of any feeling. Try to recognize what’s going on and tell someone right away. ‘one. Don’t sit silent. If I can overcome all of this, anyone can do it.

If you or someone you know is in distress or despair, call the free 24/7 Lifeline helpline on 0808 808 8000.

Video by Belfast Live videographer Harry Bateman.

Read more: My addiction hell: The NI man’s journey from self-destruction to the search for peace

Read more: ‘It’s a hidden addiction’: A Belfast man’s mission to educate young people about gambling

To get the latest news straight to your inbox, sign up for our free newsletter.

read more
Medical supplies

Bound Tree Medical donates much-needed medical supplies to war-torn Ukraine

DUBLIN, Ohio, April 21, 2022 /PRNewswire/ — Bound Tree Medical has partnered with the National Association of Emergency Medical Technicians (NAEMT) to donate 50 pallets weighing over 9 tons of desperately needed emergency tactical medical supplies to help assist personnel caring for the wounded in war-torn areas Ukraine. Given the logistical challenges of getting supplies into the country, it was important to have a direct relationship with the Ukrainian government. Bound Tree and NAEMT successfully partnered with senior officials from the Department of Foreign Affairs in Kyiv to coordinate dispatch and deployment to disaster areas.

“We are grateful to be able to work with Bound Tree to facilitate their generous donation to medical facilities and struggling personnel in Ukraine“, mentioned Bruce EvansPresident of NAEMT. “These medical supplies will help alleviate the suffering of Ukrainian civilians and soldiers injured during the war. NAEMT is honored to partner with Bound Tree on this initiative.

“Every day we strive to be our customers’ best partner,” mentioned Rob Meriweatherpresident of civil protection at Sarnova. “And when disaster strikes, our customers want someone who’s seen it before and can do what it takes to get the job done quickly – Bound Tree is happy to donate the products and lend a helping hand. this common effort, he said.

With nearly 45 years of experience, Bound Tree is the nation’s leading distributor of emergency medical supplies and safety sales equipment, assisting emergency medical services, firefighters, law enforcement , the military and other American first responders to save lives, while staying safe.

About Sarnova and Bound Tree Medical

Sarnova is the leading national specialty distributor of healthcare products in the emergency medical services (EMS) and acute care markets. The company is made up of six major business units: Bound Tree Medical, Cardio Partners, Allied 100, Digitech, Emergency Medical Products and Tri-anim Health Services. Bound Tree Medical is a leading national distributor of emergency medical equipment, supplies and pharmaceuticals for emergency services, firefighters and other first responders. For more information, visit www.sarnova.com.

About NAEMT

Formed in 1975 and nearly 72,000 members strong, the National Association of Emergency Medical Technicians (NAEMT) is the only national association representing the professional interests of all EMS practitioners, including paramedics, emergency medical technicians , emergency medical responders and other professionals providing pre-hospital care and urgent, urgent or preventive out-of-hospital medical care. NAEMT serves its members by advocating on issues that impact their ability to provide quality patient care, providing high-quality education that enhances practitioner knowledge and skills, and supporting research and innovation. in EMS. For more information, visit www.naemt.org.

Media Contact:
beth scott
Director of Marketing Communications, Sarnova
[email protected]
(800) 533-0523

SOURCE Bound Tree Medical, LLC

read more
Prescription drugs

Throwing away old prescription opioid drugs can save lives

In Florida, someone dies every two hours from an opioid overdose. That’s 12 Floridians who die and 12 Florida families who lose a loved one EVERY DAY – to something that could have been prevented.

This overdose problem is not getting better. With 2.56% of all deaths here caused by drug overdoses, Florida suffers from an overdose death rate 23.2% higher than the national average.

Prescription Drug Take Back Day is April 30 and you should take the opportunity to rid your home of unnecessary prescription drugs by returning them to an authorized collection point. Otherwise, it could lead to an overdose in your teen or another family member.

Opioid overdoses:Palm Beach County can get up to $53 million from the National Opioid Settlement. It cannot replace 3,792 dead.

How many of us have a few pills of oxycodone or other addictive and dangerous drugs left over from surgery long ago? Even if they are not up to date, these medications can be misused by a loved one, which can lead to addiction or death.

Clearly, prescription drugs play an important role in medical and behavioral health when used safely as prescribed by a physician. However, when abused, they can be deadly. In fact, in the United States, 40 people die every day from an overdose of prescribed narcotic drugs.

The recent increase in illicit drug use makes the challenge even greater. Along with soaring overdose rates, a new drug known as isotonitazene – 20 to 100 times more potent than fentanyl – has made its way to Florida. The drug, often referred to as ISO, has already been linked to more than 40 deaths nationwide in 2021, including two in Pasco County. Over the past spring break, Tampa has also seen several deaths of young adults from drugs containing fentanyl. Drugs like cocaine alone are dangerous, but with the introduction of ISO and drugs containing fentanyl, the danger and possibility of an overdose increases exponentially.

All Floridians have the potential to protect themselves and their families – not just those who can afford it. Those without insurance or the means to pay can still receive treatment for substance use disorders, through behavioral health providers overseen by Florida’s Seven Managing Entities.

The seven local managing entities work with a network of more than 300 behavioral health care providers who provide services to more than 300,000 of Florida’s most vulnerable residents – including children, pregnant women, veterans and the chronically homeless. Managing Entities ensure that quality care is delivered to people who desperately need it.

I encourage everyone to participate in Prescription Drug Recovery Day by safely disposing of your unnecessary prescription drugs. This seemingly minor gesture could save a life.

Find a nearby location here https://www.dea.gov/takebackday.

Natalie Kelly is CEO of the Florida Association of Managing Entities.

read more
Prescription drugs

Legal access to marijuana reduces prescription drug use, study finds

States where recreational marijuana is legal have seen steep declines in the use of prescription drugs for pain, depression, anxiety, sleep, psychosis and seizures, researchers have found. Photo by Atomazul/Shutterstock

When people have legal access to marijuana, they’re less likely to take certain prescription drugs, new research shows.

US states where recreational marijuana is legal have seen steep declines in the use of prescription drugs for pain, depression, anxiety, sleep, psychosis and seizures, the researchers found.

“These findings have important implications,” said study co-author Shyam Raman. He is a doctoral candidate at the School of Public Policy at Cornell University in Ithaca, NY.

“The reductions in drug use we see could result in significant savings for state Medicaid programs. The findings also indicate an opportunity to reduce the harm that can result from dangerous side effects associated with certain prescription drugs,” said Raman at a university. Press release.

For the study, researchers analyzed data from the U.S. Centers for Medicare and Medicaid Services collected from all states from 2011 to 2019, when there was an increase in states allowing personal marijuana use.

Currently, recreational marijuana use is legal in 18 states plus Washington, DC Thirty-seven states plus Washington, DC have legalized marijuana for medical purposes.

Most previous research has focused on how medical marijuana affects prescription drug use or how legal recreational use of weed affects demand for opioids. This is one of the first papers to examine the influence of legal recreational marijuana on prescription drug use, the study authors noted.

While there is a silver lining to their findings, the investigators warned that marijuana use carries risks, pointing to a number of studies that link it to a possible triggering of anxiety and psychoses such as schizophrenia.

It’s also possible that people who use marijuana to treat their health conditions don’t see their doctor as often, leading to gaps in their primary care, the researchers said.

The study was published recently in the journal Health Economics.

More information

There’s more on marijuana at the US National Institute on Drug Abuse.

Copyright © 2022 Health Day. All rights reserved.

read more
Generic drugs

Apex expects the upward trend in generic drugs to continue

KUALA LUMPUR: Apex Healthcare Bhd envisions further growth in the generic drug segment of the pharmaceutical and healthcare industry.

Generic drugs have emerged as a substitute for expensive, patented drugs.

The company said in its 2022 annual report that the upward trend in generic drugs is expected to continue due to an aging population, rising affluence and increasing life expectancy.

He noted that the 2019 National Health and Morbidity Survey for Malaysia showed that non-communicable diseases accounted for 71% of premature deaths and over 70% of the disease burden.

Commenting on its business performance, Apex said the group has been successful in seizing new opportunities through identifying and supplying products with changing demand in a changing pandemic environment.

“Strategic initiatives implemented earlier to increase revenues through increased new product launches, contract manufacturing services, government tenders and exports have also enabled us to both diversify and increase its revenue base.

“These enabled the group to achieve good revenue and profit growth despite the difficult business circumstances caused by the pandemic,” Apex said.

He noted that increased vaccination rates in Malaysia helped the company’s sales pick up in the second half of 2021, especially to private sector clinics and pharmacies, enabling Malaysian private sector sales to achieve growth. revenues of 12% over a full year compared to 2020. .

Its Singapore operations saw private sector sales increase 43% from 2020 as demand for respiratory products increased.

“Sales growth is also the result of a planned restructuring of the sales and marketing team for greater focus and efficiency,” he added.

read more
Medical products

Personal Mobility Devices Market Size and Forecast

New Jersey, United States – personal mobility device market Research Report provides you with detailed and accurate analysis to strengthen your position in the market. It provides the latest updates and powerful insights on the Personal Mobility Devices industry to help you improve your business strategy and ensure strong revenue growth for years to come. It elucidates the current and future market scenarios and lets you understand the competitive dynamics of the Personal Mobility Devices market. The market segmentation analysis provided in the research report shows the performance of different product segments, applications, and regions in the Personal Mobility Devices market.

The report includes validated and revalidated market data such as CAGR, gross margin, revenue, price, production growth rate, volume, value, market share and year-on-year growth on the other. We use the latest primary as well as secondary research techniques to compile this comprehensive Personal Mobility Devices Market report. As part of the regional analysis, we studied key markets such as North America, Europe, India, China, Japan and MEA. Profiles of leading companies are based on various factors including markets served, production, revenue, market share, recent developments, and gross profit margins. A section dedicated to market dynamics with in-depth analysis of drivers, restraints, opportunities, influencers, challenges and trends.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=37564

Key Players Mentioned in the Personal Mobility Devices Market Research Report:

NOVA Medical Products, Performance Health, Drive DeVilbiss Healthcare, Medline Industries Invacare Corporation, Carex Health Brands Kaye Products Rollz International, GF HEALTH PRODUCTS and Briggs Healthcare

The report gives a good overview of the main macroeconomic factors that have a significant impact on the growth of the Personal Mobility Devices market. It also provides absolute dollar opportunity analysis which is essential for identifying opportunities for revenue generation and increasing sales in the Personal Mobility Devices market. Market players can use the qualitative and quantitative analysis provided in the report to fully understand the Personal Mobility Devices market and make great strides in the industry in terms of growth. The overall size of the Personal Mobility Devices market and the overall size of each segment studied in the report are precisely calculated based on various factors.

Personal Mobility Devices Market Segmentation:

Personal Mobility Devices Market, By Product

• Wheel chairs
• Scooters
• Walking aids

The report is the best compilation of different types of segmental analyzes of the Personal Mobility Devices Market performed from different perspectives. The analysts’ pragmatic approach to studying different market segments and top-down and bottom-up approaches to forecasting the size of their markets makes the Personal Mobility Devices research study unique and accurate. Reliable primary sources such as CTOs, Physicians, VPs, CEOs, and supply and demand side industry experts were consulted to validate and revalidate the market and market figures. ‘other information. Secondary sources such as Bloomberg, databases, white papers, press releases and company reports were used to collect market information and data.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=37564

Scope of the Personal Mobility Devices Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the Personal Mobility Devices market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the personal mobility device market?

2. How will the personal mobility device market evolve in the next five years?

3. Which products and applications will capture the lion’s share of the personal mobility device market?

4. What are the drivers and restraints of the Personal Mobility Devices Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Personal Mobility Devices market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/personal-mobility-devices-market/

Visualize the Personal Mobility Devices Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Personal Mobility Devices Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical supplies

Medical Supplies Market Size and Forecast

New Jersey, United States – Medical supplies market Research Report provides you with detailed and accurate analysis to strengthen your position in the market. It provides the latest updates and powerful insights on the medical supplies industry to help you improve your business strategy and ensure strong revenue growth for years to come. It elucidates the current and future market scenarios and allows you to understand the competitive dynamics of the Medical Supplies market. The market segmentation analysis provided in the research report shows the performance of different product segments, applications, and regions in the Medical Supplies market.

The report includes validated and revalidated market data such as CAGR, gross margin, revenue, price, production growth rate, volume, value, market share and year-on-year growth on the other. We use the latest primary as well as secondary research techniques to compile this comprehensive Medical Supplies Market report. As part of the regional analysis, we studied key markets such as North America, Europe, India, China, Japan and MEA. Profiles of leading companies are based on various factors including markets served, production, revenue, market share, recent developments, and gross profit margins. A section dedicated to market dynamics with in-depth analysis of drivers, restraints, opportunities, influencers, challenges and trends.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=144345

Key Players Mentioned in the Medical Supplies Market Research Report:

Johnson & Johnson, Coloplast Group, Fresenius Medical care AG & Co. KGaA, Teleflex Incorporated, Terumo Japan, Stryker, Merit Medical Systems, Cook Medical, Abbott ConvaTec Group Plc.

The report gives a good overview of the main macroeconomic factors that have a significant impact on the growth of the medical supplies market. It also provides absolute dollar opportunity analysis which is essential for identifying revenue-generating and growing sales opportunities in the Medical Supplies market. Market players can use the qualitative and quantitative analysis provided in the report to fully understand the Medical Supplies market and make great strides in the industry in terms of growth. The overall size of the Medical Supplies market and the overall size of each segment studied in the report are precisely calculated based on various factors.

Medical Supplies Market Segmentation:

Medical Supplies Market, By Type

• Individual protection equipment
• Disinfectants
• Intubation and ventilation supplies
• Infusion and injectable supplies
• Diagnostic supplies
• Others

Medical Supplies Market, By Application

• Cardiology
• Infection control
• Respiratory
• Radiology
• Wound care
• Others

Medical Supplies Market, By End User

• Hospitals
• Clinics/Doctors’ offices
• Others

The report is the best compilation of different types of segmental analyzes of the Medical Supplies Market done from different perspectives. The analysts’ pragmatic approach to studying different market segments and top-down and bottom-up approaches to forecasting the size of their markets makes the Medical Supplies research study unique and accurate. Reliable primary sources such as CTOs, Physicians, VPs, CEOs, and supply and demand side industry experts were consulted to validate and revalidate the market and market figures. ‘other information. Secondary sources such as Bloomberg, databases, white papers, press releases and company reports were used to collect market information and data.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=144345

Scope of the Medical Supplies Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the medical supplies market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the medical supplies market?

2. How will the medical supplies market evolve over the next five years?

3. Which product and which application will occupy the lion’s share of the medical supplies market?

4. What are the drivers and restraints of Medical Supplies Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Medical Supplies market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/medical-supplies-market/

Visualize the Medical Supplies Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the medical supplies market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Prescription drugs

Misguided bill raises prescription drug bills | Opinion






Amanda Massy


Governor Jared Polis kicked off this year’s session with a laudable promise: “Saving money in Colorados and keeping our state affordable is my top priority this session.” Health insurers support this sentiment, but key features of this year’s legislative program undermine Polis’ commitment.

Nowhere is this more apparent than in the recent introduction of Bill 22-1370: Coverage Requirements for Health Care Products. The legislation purports to help reduce consumer drug expenditures, but in reality will increase premium costs for Coloradans by approximately $17 to $36 per member per month. This equates to a 5.7% to 13.6% increase in the premium cost for each member per month to line the pockets of Big Pharma. This will increase health care costs for Coloradans.

This bill eliminates the tools carriers use to mitigate the high prices pharmaceutical companies set for their drugs — the same tools used by Medicaid and Medicare to lower costs for consumers. These tools include step therapy, formulary levels, and drug discounts to help ensure consumers get the most clinically appropriate and cost-effective prescriptions to reduce premiums and out-of-pocket costs. In Colorado, pharmaceutical costs are estimated to have increased by 87% between 2013 and 2019.

Yet rather than do anything to bring down the price of prescription drugs, the bill sets in place policies that are in direct contradiction to the administration’s own 2021 report on reducing drug costs. by prescription in Colorado. In that same report, the Polis administration says lawmakers should stop at the policy of consumer rebates at point-of-sale, “because it can incentivize consumers to take — and reward manufacturers for promoting — drugs.” more expensive brands.

The report also states that “step therapy helps reduce costs by first encouraging the use of safer and/or less expensive drugs, then allowing the patient to ‘switch’ to another drug if necessary to achieve desired results”. However, this bill includes the very policies the administration has warned against.

Nothing in this bill will reduce the prices of pharmaceuticals, which both consumers and carriers want. Instead, it will actually increase the amount of money going to Big Pharma. But don’t take my word for it. Read the US House of Representatives drug prices report released in December. According to a three-year survey, pharmaceutical companies are:

“Raise prices on the dropout, especially when they succeed in delaying or blocking competition. Internal documents reveal that the companies raised prices to meet ever-increasing revenue targets, which in some cases were tied to higher salaries for executives.

“Several companies have also used patient assistance programs and donations to third-party organizations – which were apparently intended to help patients afford expensive drugs – as tools to gain positive public relations, increase sales and increase The committee’s investigation found new evidence that companies have been emphasizing the significant returns on investment from these programs in the form of increased sales, particularly for drugs approaching loss of value. For example, internal documents from Teva and AbbVie indicate that these donations were intended to boost sales or attract patients who might not otherwise have used the companies’ drugs.

Health insurance providers have worked hard to reduce premiums by 28% since 2019 and expand insurance choices across the state. But further premium cuts aren’t possible when the administration pushes policies it already knows run counter to saving money on health care.

Coloradons across the state should be clear — we expect the governor to deliver on his promise of affordability and stop this bill.

Amanda Massey is executive director of the Colorado Association of Health Plans.

read more
Medical products

Women’s Health Rehabilitation Products Market Size and Forecast

New Jersey, United States – Women’s Health Rehabilitation Products Market Research Report provides you with detailed and accurate analysis to strengthen your position in the market. It provides the latest updates and powerful insights on the Women’s Health Rehabilitation Products industry to help you improve your business strategy and ensure strong revenue growth for years to come. It elucidates the current and future market scenarios and allows you to understand the competitive dynamics of the Women’s Health Rehabilitation Products market. The market segmentation analysis provided in the research report shows the performance of different product segments, applications, and regions in the Women’s Health Rehabilitation Products market.

The report includes validated and revalidated market data such as CAGR, gross margin, revenue, price, production growth rate, volume, value, market share and year-on-year growth on the other. We use the latest primary as well as secondary research techniques to compile this comprehensive Women’s Health Rehabilitation Products Market report. As part of the regional analysis, we studied key markets such as North America, Europe, India, China, Japan and MEA. Profiles of leading companies are based on various factors including markets served, production, revenue, market share, recent developments, and gross profit margins. A section dedicated to market dynamics with in-depth analysis of drivers, restraints, opportunities, influencers, challenges and trends.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=22158

Key Players Mentioned in the Women’s Health Rehabilitation Products Market Research Report:

Accord Medical Products, BSN medical, Carib Rehab, Cornerstone Chiropractic, DeRoyal, EMS Physio, GE Healthcare, GPC Medical, Meyer Physical Therapy, Midtown Chiropractic, PROSPINE Health and Injury Center, Pelvic Health and Rehabilitation, Pure Health Chiropractic, Sportstek, Win Health Medical, Zynex

The report gives a good overview of the main macroeconomic factors that have a significant impact on the growth of the Women’s Health Rehabilitation Products market. It also provides absolute dollar opportunity analysis which is essential for identifying opportunities to generate revenue and increase sales in the Women’s Health Rehabilitation Products market. Market players can use the qualitative and quantitative analysis provided in the report to fully understand the Women’s Health Rehabilitation Products market and make great strides in the industry in terms of growth. The overall size of the Women’s Health Rehabilitation Products market and the overall size of each segment studied in the report are precisely calculated based on various factors.

Women’s Health Rehabilitation Products Market Segmentation:

Women’s Health Rehabilitation Products Market by Product

• Orthopedic care
• Urinary incontinence
• Breast cancer care
• Pregnancy and postpartum care

Women’s Health Rehabilitation Products Market By Application

• Hospitals
• Clinics

The report is the best compilation of different types of Women’s Health Rehabilitation Products market segmental analysis done from different perspectives. The analysts’ pragmatic approach to studying different market segments and top-down and bottom-up approaches to forecasting their market sizes makes the Women’s Health Rehabilitation Products research study unique and accurate. Reliable primary sources such as CTOs, Physicians, VPs, CEOs, and supply and demand side industry experts were consulted to validate and revalidate the market and market figures. ‘other information. Secondary sources such as Bloomberg, databases, white papers, press releases and company reports were used to collect market information and data.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=22158

Scope of the Women’s Health Rehabilitation Products Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the Women’s Health Rehabilitation Products Market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the Women’s Health Rehabilitation Products Market?

2. How will the women’s health rehabilitation products market develop in the next five years?

3. Which product and application will occupy the lion’s share of the women’s health rehabilitation products market?

4. What are the drivers and restraints of the Women’s Health Rehabilitation Products Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Women’s Health Rehabilitation Products market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/women-health-rehabilitation-products-market/

Visualize Women’s Health Rehabilitation Products Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Women’s Health Rehabilitation Products Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Generic drugs

Doctors must only prescribe generic drugs or face measures, says Baghel

Chhattisgarh Chief Minister Bhupesh Baghel on Monday called for action against doctors in public hospitals after learning they were prescribing brand name drugs and not generic drugs.

It was holding a review meeting of the Department of Urban Administration and Development and the Department of Environment and Housing here, an official statement said on Monday.

During a review of the ‘Shri Dhanwantri Generic Medical Store’ scheme, he called for strict action against government doctors prescribing brand name drugs.

The Chief Minister was told that despite repeated instructions, doctors were prescribing branded drugs to patients.

As a result, the Principal Secretary, Health and Family Welfare, Dr Maninder Kaur Dwivedi, has written to all District Collectors and Chief Medical Officers of Health (CMHOs), to ensure that doctors only prescribe generic medicines.

On October 23, 2021, the Chief Minister had launched the flagship generic drug store Shri Dhanwantri to offer a 50-70% discount on the maximum retail price of drugs.

Stores are required to sell 251 types of generic drugs and 27 surgical products.

Currently, 159 medical stores are operating in the state against a target of 188 in 169 city agencies. The program had benefited 17.92 lakh citizens.

read more
Generic drugs

Repurposing generic drugs reduces the time and cost of developing treatments

Discovering new ways to use existing drugs can happen intentionally or by chance.

Sometimes doctors or patients notice an unexpected beneficial effect of a drug. An example is sildenafil, a drug originally developed to treat severe chest pain caused by coronary heart disease. Although sildenafil failed in clinical trials, researchers noticed that one of its side effects was the induction of erections. This led to its successful rebranding as erectile dysfunction drug Viagra.

Most of the time, when drugs are reused for diseases or conditions for which they were not originally intended, it is done deliberately. As scientists raced to develop treatments for COVID-19, drug redirection has come into the spotlight for good and bad reasons.

As a researcher focused on drug discovery and development, I have seen the potential for redirection and the challenges it faces. Although finding new uses for drugs that have already been tested and approved for safety by the FDA can dramatically reduce development time and cost, financial and logistical hurdles can make it difficult to get to market.

The success of thalidomide

When the redirection is successful, a drug that is ineffective or harmful for one condition can save the life of others.

One such drug is thalidomide, first approved as a treatment for morning sickness. It gained notoriety in the late 1950s when it caused birth defects in an estimated 10,000 infants worldwide, leading to regulatory and drug development changes that included increased developmental toxicity testing . Thalidomide was banned globally in the late 1960s.

In the 1990s, however, researchers discovered that thalidomide inhibits angiogenesis, or the growth of new blood vessels that supply nutrients and oxygen to tumors. Its new use as a treatment for a blood cancer called multiple myeloma has finally achieved clinical and commercial success. This has led to the development of improved versions of the drug that treat cancer with reduced side effects.

Scientists continued to find other therapeutic uses for thalidomide.

When researchers discovered that thalidomide targets a molecule in the body that marks other proteins for destruction, they exploited this feature in an emerging technology called PROTAC. Many drugs work in the body by inhibiting a particular target that produces an adverse effect, usually reversibly and temporarily. PROTACs, on the other hand, are a type of drug that can completely destroy the target. This potentially increases the effectiveness of the drug and reduces the risk of drug resistance.

An example is bavdegalutamide, a PROTAC that combines thalidomide with an inhibitor typically used to treat prostate cancer. This inhibitor works by blocking a target that supplies the tumor with hormones that help it grow. An ongoing phase 2 clinical trial of bavdegalutamide is based on the idea that killing the target would cut off the hormone supply to tumors and stop their growth more effectively than conventional inhibitors.

Researchers currently produce PROTACS often by repurposing existing drugs. With promising results underway, 2021 has seen the launch of a wave of clinical trials testing PROTACs as a treatment for a number of different cancers.

Reassignment for COVID-19

Researchers have used a myriad of drug redirection approaches during the COVID-19 pandemic, ranging from educated guesses to large-scale drug screening and data mining from millions of electronic health records. Regardless of how researchers decide which drugs to reuse, all candidates must demonstrate strong clinical benefit in people before they can be cleared or approved for any proposed new use by the FDA.

My research team and I tested 1,425 FDA-approved drugs in human cells infected with COVID-19 and found 17 candidates for redirection for further investigation. Several of the leads we identified have since entered early clinical trials, including drugs originally intended to treat leprosy and prostate cancer, as well as a milk-derived supplement.

Researchers launched hundreds of clinical studies early in the pandemic to test drug redirection candidates for COVID-19. There have been some notable successes, including the generic antidepressant fluvoxamine, which reduced the risk of hospitalization by 32% in a clinical study. A meta-analysis of fluvoxamine and two other COVID-19 antiviral drugs, molnupiravir and Paxlovid, found that they all provided protective benefits against COVID-19 with comparable safety profiles.

Unlike these newer COVID-19 antivirals, however, fluvoxamine has a 40-year track record of safely treating depression and obsessive-compulsive disorder. Despite this, fluvoxamine has not been cleared for emergency use by the FDA, and the National Institutes of Health says there is insufficient evidence for its use against COVID-19.

The Challenges of Drug Discovery

Successful drug repurposing highlights the difficulty of predicting the off-target effects of new treatments.

Eflornithine, for example, is a drug that has been shown to be ineffective against cancer – but it turns out to inhibit facial hair growth in women and cure a parasitic infection called trypanosomiasis or sleeping sickness. It’s often not immediately obvious why a drug would effectively treat two seemingly different health conditions like these.

There are approximately 2,500 drugs approved by the FDA, and an average of 46 new drugs are approved each year. However, more than 90% of drugs that enter clinical trials fail. This percentage rises to 97% for cancer drugs. Although many shots are needed to produce a viable drug, each failed drug is a candidate for reuse. Researchers like me collected these “failed” compounds for further testing, combing through research papers, patents, and clinical trial databases to find candidates for reuse. Some labs have used artificial intelligence to automate this process.

But it can be difficult to determine which drugs are available for reuse. While a drug development database suggests that there are 47,000 compounds already tested ready for re-use, there is no central repository for this information.

Marketing Landscape

Drug reuse comes up against an intellectual property barrier. Reuse is more accessible with generic drugs that do not have patents limiting their use for other conditions. But there are fewer opportunities for profit with generics than with new drugs.

Patents allow drug suppliers to have a sales monopoly for a period of time. Repurposed drugs typically receive “use patents” that protect the use of an existing drug for a particular new disease. But companies see this kind of protection as less valuable than a “composition of matter” patent that restricts drug sales to patent holders only. An FDA analysis found that a drug with two drug suppliers resulted in an average price reduction of 39%, and six or more suppliers resulted in a 95% reduction. With less patent protection on a drug, more competitors can enter the market and manufacturers make less money.

Because of this perceived lack of market potential, drug repurposing is typically left to academic institutions that lack the resources to obtain new or repurposed drugs through the costly approval process.

It’s possible that if fluvoxamine was a new drug in development with patent protection at a major pharmaceutical company, it would have already obtained FDA approval to treat COVID-19. But as it stands, fluvoxamine is a widely available generic that any doctor can prescribe “off-label” to treat conditions that haven’t been approved by the FDA, such as COVID-19.

This leads to a tragedy of the commons in which no company will invest in the clinical trials needed to bring a repurposed drug to market, because the resulting benefits would be immediately shared with all competitors.

Bringing a new drug to market is a long and expensive process with a high failure rate. When the pharmaceutical industry cannot justify the development of a new drug due to low return on investment, drug repurposing can fill the void. Federal support could make repurposing more commercially attractive, enticing companies to enter the market and boosting this cost-effective way to meet unmet medical needs.

This article is republished from The Conversation under a Creative Commons license. Read the original article.

read more
Prescription drugs

Medicare negotiation for prescription drugs

Published: 04/17/2022 07:01:40

Modified: 04/17/2022 07:00:22

Not long ago, a study was done confirming that 1 in 5 granite staters were rationing their prescription medication, taking less than ordered due to its unaffordable price. And there are many stories attesting to the terrible and permanent consequences that some people have suffered because of it. We’ve also all seen the Pharma-sponsored attack ads that misrepresent the results of Medicare negotiations for reduced prices. They are threatened by any action that will interfere with their profits. They claim that the exorbitant cost of research and development makes their price points necessary.

First, their research is largely funded by taxpayers’ money and second, their profit levels run into the billions after all expenses are taken into account. These are excessive prices. New Hampshire has done a good job of passing some prescription drug laws in recent years. That said, at the federal level, we also need to do better. This is where the negotiation of health insurance must be addressed. We would like to see: 1. Medicare Part D cost caps 2. Penalize companies that increase drug prices faster than inflation 3. Cap out-of-pocket expenses for insulin nationwide 4. Allow negotiation of Medicare. We know that families across the country are grappling with drug costs. Please join AARP in challenging our senses. Shaheen and Hassan to support the passage of comprehensive prescription drug reform in the US Senate that has already passed the House. These common sense reforms have been promised for years. Let’s do that !

Bev Cotton

We are

read more
Medical supplies

Ukrainian recipients react to fire equipment and medical supplies sent overseas – NBC Connecticut

The Connecticut community continues to come together in support of Ukraine. We brought you a story this weekend about how the South Fire District of Middletown organized a drive-in for fire equipment and medical supplies.

On Friday, these items were being prepared for shipping. More than 300 boxes and 12,000 pounds of equipment and supplies have been delivered to Ukrainian moving company Meest in New Jersey as it prepares overseas shipments.

“It was very rewarding to see this go from the cradle to the grave,” said Fire Chief Jim Trzaski of the Southern District Fire Department.

“All the people in Meest are from Ukraine and they were so happy to see this shipment there, knowing that it’s not just going for humanitarian needs, but actually for first responders,” he said. for follow-up.

But as the war in Ukraine rages on with no sign of an end in sight, the conditions of what it’s like to face the unknown are described:

“Day by day Ukrainian territory is being bombed by the Russians and we have a lot of fires in towns in a forest and fields. And they are working around the clock and this is not a typical situation,” he said. said Trzaski.

With the constant battle of the fire, Michael Radigan, who works with the Ukrainian Catholic University but functions as an English liaison officer for the Lviv Oblast Fire Agency, portrays how much the Ukrainian community has really need for medical equipment and supplies.

“Just imagine you’re working in a primary critical aid unit and you don’t have meds or you’ve been in a fire brigade and you’re also picking up rubble, your equipment is damaged while you’re working and you don’t have equipment to go back to,” Radigan said.

The items are expected to arrive in Ukraine in the coming weeks.

read more
Medical supplies

SLO County sends medical supplies to Ukraine

Refugees fleeing Irpin, Ukraine. Photo by Josh Friedman

By JOSH FRIEDMAN

San Luis Obispo County is sending surplus medical supplies to Ukraine to support humanitarian efforts in the war-torn country. [KCOY]

The county is sending at least 100,000 medical gloves, 1,000 or more ready-to-eat meals, 300 medical scrubs and other miscellaneous medical items. The medical supplies had been purchased to prepare for a surge in COVID-19 hospitalizations which did not occur.

At the start of the pandemic, the SLO County Public Health Department purchased more than 100,000 medical items for the Alternate Care COVID-19 Treatment Center that was set up at Cal Poly. The facility was ultimately unnecessary as local hospitals managed to cope with the number of COVID-19 patients who were admitted.

Vince Pierucci, director of SLO County Emergency Medical Services, said medical supplies sent to Ukraine had expiration dates. They must be used or they will end up in a landfill, Pierucci said.

“The last thing we want is to pollute our environment and not use these items that were purchased to help people,” Pierucci said. “So we thought it was a great opportunity to help Ukrainians.”

Local moving company Meathead Movers is helping the county send medical supplies to Ukraine. Meathead Movers packs the supplies and delivers them to the Port of Los Angeles, from where they are shipped to Ukraine.

read more
Prescription drugs

Orcas Island residents can get rid of prescription drugs at a take-back event

Orcas Island residents can get rid of prescription drugs at a take-back event

The Coalition for Orcas Youth (COY) will be hosting a prescription drug take-back event on Saturday, April 30, 10 a.m. to 2 p.m., at Key Bank Drive Thru 487 Main St, Eastsound, WA. This event allows the public to dispose of unused or expired prescription medications in a safe and easy way. Both prescription and over-the-counter medications will be accepted. Medications can remain in their original container and labels do not need to be removed. Medications that are not in their original container will also be accepted.

This recovery event supports a Washington State Health Care Authority campaign called Starts with One. This campaign informs and educates young adults, their parents and seniors about the dangers of prescription drug abuse and the importance of safe storage and disposal of prescription opioids.

According to the campaign’s website, “75% of opioid abuse begins with people using drugs that weren’t prescribed to them – usually taken by a friend or family member.” Simple measures, such as the safe disposal of medications, can prevent their misuse. Attending these recovery events is something individuals can do to help fight the opioid epidemic and protect their loved ones. For more information on the HCA Starts with One campaign, visit www.getthefactsrx.com. For more information about the Coalition for Orcas Youth, visit coalitionfororcasyouth.org.

read more
Medical products

India capitulates to EU over TRIPS waiver for Covid-19 medical products

The compromise reached puts all the odds on its side against the poorest countries. Additionally, eligibility is limited to developing WTO countries that exported less than 10% of global vaccines in 2021. This would exclude Brazil, China, and non-WTO countries such as Kosovo, Palestine, Iran, Serbia and Syria.

Chronology of negotiations

In October 2020, India and South Africa submitted a proposal which called for the relinquishment of patents, but also of industrial designs, copyrights and trade secrets which are protected by the agreement of WTO on TRIPS.

In May 2021, a revised proposal was tabled which specified that the TRIPS waiver would only apply to vaccines, diagnostics, therapeutics, medical devices and personal protective equipment related to COVID-19 and would remain in effect for at least three years. .

In December 2021, the WTO Secretariat convened a meeting between the four parties – South Africa, India, the US and the EU – but it was held in two formats. For one meeting, only quad trade and trade ministers met and in the other meeting, only negotiators from these four countries met. Indian Commerce Minister Piyush Goyal attended these meetings. Normally, negotiators and ministers attend meetings together. In the next round of online meetings, India met the US and South Africa met the EU.

On March 11, 2022, there was a meeting of the four ministers only where the compromise was agreed. This is after EU officials sent a note to their member countries on the compromise reached.

The United States Trade Representative (USTR) released a statement on March 16 indicating that a compromise had been reached but countries had yet to agree on the final test. A little after, WTO Director General, Ngozi Okonjo-Iweala said the details of the deal were not yet settled.

However, India remained silent on the issue after the compromise was reached. In November 2021, a senior Commerce Ministry official had reiterated that India would continue to demand waiver of intellectual property rights for COVID-19 vaccines and supplies. India had affirmed that it would ensure that the interests of developing nations were not compromised.

read more
Medical supplies

Michigan surgeon collects medical supplies for Ukrainian hospitals

ANN ARBOUR, Mich. – In the midst of the nightmare that unfolds in Ukrainea local surgeon goes above and beyond to help you.

Michigan Medicine plastic surgeon Dr. David Brown gathered medical supplies to send to the war zone.

Every September for the past eight years, Dr. Brown has traveled to Ukraine with Doctors Collaborating to Help Children Corp. There, surgeons like Dr. Brown perform burn reconstructions on children.

He remains in contact with the medical staff he met in Ukraine.

“We have pictures of the hospital in Dnipro, which is in the east of Ukraine where we were in September, where they were bombed and had to move the babies from the intensive care unit,” said said Dr. Brown.

He knows that as doctors they can’t solve a war, but knows that every little bit of support helps, so Dr. Brown has organized a drive for medical supplies.

A d

“We are sending supplies that are urgently needed to emergency rooms, trauma centers, children’s hospitals,” Dr. Brown said.

The list of items includes gauzes, bandages and syringes.

Local hospitals and nonprofit organizations donated supplies.

Two weeks ago, the first plane full of supplies left for Poland, then trucks delivered them to Ukrainian hospitals.

Dr Brown wants to send more and collects monetary donations here.

“Every dollar you contribute goes directly to funding medical supplies and missions in Ukraine without any administrative costs,” Dr. Brown said. “It’s also tax deductible.”

Copyright 2022 by WDIV ClickOnDetroit – All Rights Reserved.

read more
Medical products

Free offers of medical products – No violation of the prohibition on promotional gifts under Hwg 7(1) when the purchase price is refunded in full

In the case at issue, the plaintiff, on the basis of Sections 8, 3, 3a of the German Unfair Competition Act (UWG) in conjunction with Section 7(1) Nr. 1 of the German Health Advertising Act (HeilmittelwerbegesetzHWG), sought an injunction against defendant’s promotional offer “Incontinence Pants – FREE TRIAL” which was challenged as in violation of competition law.

Specifically, the defendant had affixed a folded sticker containing the words “FREE TRYon the packaging of its medical product. The inside of the sticker contained instructions on how to obtain a refund of the purchase price after purchasing the product by uploading to the defendant’s website a photo of the payment receipt and the promotional package and providing the name, address and bank details, after which the purchase price would be refunded within 14 days.

The Higher Regional Court of Cologne (judgment of 17 December 2021, file no. 6 U 91/51) upheld the decision of the Regional Court of Cologne (judgment of 25 May 2021, file no. 33 O 60/20) to reject the action and dismissed the appeal against said decision.

In his appeal, the plaintiff argued that the defendant could not rely on the exceptions provided for in § 7, paragraph 1, no. 1 of the HWG, because the limit of the lower value is exceeded when the purchase price exceeds at least eight euros. The other exception in Section 7(1) No. 2(a) of the HWG was irrelevant because the public would not view reimbursement of the purchase price as a gift, but rather as acquiring the product. Furthermore, a full refund of the purchase price is not covered by this provision.

The Higher Regional Court, on the other hand, found no violation of Section 7 (1) HWG. According to this provision, it is in principle inadmissible to offer, advertise or grant advantages and other promotional gifts (goods or services). The term “promotional gift” should be interpreted broadly and includes any free gift in connection with the purchase of a product or service. In the opinion of the Tribunal de Grande Instance, the reimbursement of the purchase price described above constitutes such a free gift. However, the the exception under Section 7 (1) No. 2 (a) HWG applies here, whereby the benefit or promotional gift is permitted if granted for a specific amount of money or for an amount of money calculated in a certain way.

In this case, the Cologne courts therefore did not consider the product itself as the gift, but rather the purchase price reimbursed under the conditions described. Therefore, the exception for low value items under Section 7(1) No. 1 HWG was not relevant.

The decisive factor in this respect is that the product must first be fully paid for by the consumer. The consumer therefore does not understand the message on the sticker to mean that the product is given away free of charge. Also, the consumer is informed of similar promotions, so he will take into account the additional information on the reimbursement conditions appearing inside the sticker. In addition, the refund relates to the total purchase price of the product and therefore to a “specified sum of money or for a sum of money calculated in a certain way”. The fact that the full purchase price is refunded is also not in contradiction with this, since the wording of Article 7(1)(2) (a) of the HWG does not provide for any relative or absolute limitation on the amount of the donation. Accordingly, in the opinion of the Higher Regional Court, the except for Section 7 (1) No. 2 (a) HWG does not to fail due to lower limit value of Section 7 (1) No. 1 HWG nor is it in conflict with this provision.

The Higher Regional Court of Cologne thus follows the decision of the Higher Regional Court of Hamburg, which had previously rejected a previous request for an injunction (judgment of 20 June 2019, file no. 3 U 137/18).

The decision concerns an interesting and finely drawn line between the two exceptions to the fundamental prohibition on promotional gifts under Section 7(1) HWG and illustrates the complexity surrounding the legal assessment of promotional activities for drugs and products. medical, in particular in the planning of such promotional activities. It is strongly recommended to seek legal advice here.

This judgment is one of many decisions which raise the bar for the promotion by pharmaceutical companies of corresponding products. Particular attention should always be paid to the prohibition of promotional gifts under Section 7 HWG discussed here. See also the articles “Mandatory information in pharmaceutical advertising” of the September 7, 2021and “Provision of Complimentary Samples to Pharmacies Pursuant to Section 7 HWG” of April 14, 2021.

read more
Generic drugs

FDA outlines criteria for granting waivers for pH adjusters in generic drugs

Posted on April 13, 2022 | By Joanne S. Eglovitch

The United States Food and Drug Administration (FDA) has released draft guidelines on its criteria for authorizing the use of pH adjusters in parenteral, ophthalmic, or abbreviated otic new drug applications (ANDAs). The FDA said that under certain circumstances, certain differences in pH adjusters “may be scientifically appropriate and acceptable.”

These guidelines outline the process for requesting exemption from complying with generic drug regulations under §314.94(a)(9)(iii) and (iv). These regulations specify that a drug product intended for parenteral, ophthalmic or otic use in general “must contain the same inactive ingredients and at the same concentration as the reference drug indicated by the applicant”.

Since the publication of these regulations, the agency has changed its thinking on pH adjusters, considered as excipients.

“Over time, there has been increased interest and questions about waivers of applicable inactive ingredient requirements for pH adjusters in ANDAs,” the guidance states. “The FDA’s current thinking is that pH adjusters operate in such a way that, under certain circumstances, a waiver of the inactive ingredient requirements of §314.94(a)(9)(iii)-(iv) for a pH adjuster in a generic drug produced for parenteral, ophthalmic or otic use may be appropriate.

The FDA concluded that “there may be circumstances in which an ANDA applicant can establish that a difference greater than 5% in the amount of pH adjuster in an ANDA product compared to the [reference listed drug] RLD would not change the final characteristics of the proposed drug product in an unacceptable way.

The agency said pH adjusters are typically used “as needed to achieve a specified pH range in the drug product.” The primary function of a pH adjuster “is to alter the equilibrium concentration of hydronium ions in solution (i.e. pH)”.

The following items must be submitted to support a waiver request:

  • pH, buffering capacity, or both if applicable with respect to the RLD;
  • The osmolality relative to the RLD;
  • Viscosity with RLD; or
  • Electrophoretic mobility with the RLD.

In addition to this documentation, the FDA recommends that waiver requests include the following:

  • An explanation of why the applicant cannot comply with the requirements of 21 CFR 314.94(a)(9)(iii) and (iv);
  • A description of an alternative submission that satisfies this requirement; or
  • Other information justifying a derogation.

The agency will grant a waiver request if the applicant’s compliance with the requirement is deemed unnecessary, or if the applicant’s alternative submission supports the waiver.

The FDA recommends that waiver requests be submitted through controlled correspondence.

The deadline for submitting comments is June 14.

FDA Guidelines

© 2022 Society of Regulatory Affairs Professionals.


read more
Medical products

Precision Medical Products, Inc. Announces Steve Ingel as New CEO

New year, new precision medical products: the company will have a new leader, in partnership with the longtime founder and current CEO Jeremy Perkins. Stepping into the shoes of Perkins will be a respected industry veteran Steven Ingelwho will immediately become President and CEO of Precision Medical Products, Inc.

CARROLLTON, TX, April 13, 2022 /PRNewswire/ — Precision Medical Products today announced the appointment of Steven Ingel to the President and CEO of Precision Medical Products, Inc. Ingel’s official start date was April 4, 2022. At that time, he succeeded the current President and CEO of Precision Medical, Jeremy Perkins, who will remain with the company and assume the role of executive chairman of the board. In this new role, Mr. Perkins will identify strategies, business opportunities and new technology architectures to develop precision medical products. “Steve Ingel brings extensive experience in medical devices and digital health with a proven track record of growth, margin expansion and overall financial performance. His broad and deep industry experience, combined with his respected leadership and team spirit, make him the perfect fit to continue our important work at Precision Medical,” said Jeremy Perkins.

read more
Medical supplies

Redcliff family sends medical supplies to Ukraine

“We mainly sought out friends, acquaintances, through social media and got decent support,” says Alison. “The next step is to go out into the community and find as much as you can. We can take up to 10 suitcases of supplies. We need help to finance 10 suitcases of supplies.

The supplies will go to Lutsk, the town where Asher was adopted from. Raymond plans to fly with the supplies collected here to Poland on April 29. From there, the supplies will be transported to the Ukrainian border. Alison says they have prepared for the quick turnaround and are still looking for more help.

” Hurry up. We order most of our supplies online, so we need to be aware of shipping times to get items to us. We have raised $6,000 so far. We’d love to see it end at around $10,000, or even up to $15,000. They can use whatever we can bring.

Their children also helped raise funds.

“They decided to sell candies and bags of candy, and they did very well. They brought in some of their teachers, some of their friends from the neighborhood and they were able to raise $153 to help us.

The family is grateful that Asher doesn’t have to experience what is happening overseas.

“We feel incredibly lucky to have been able to bring him home,” says Raymond. “It’s been four years, but just to be able to say he’s here and he doesn’t have to go through what all these people are going through right now is really lucky for him.”

The Vis family is setting up a GoFundMe for anyone in the community who wants to donate. If you would like more information on how to donate, or would like to learn more about Asher’s story, you can visit the family’s Facebook page, Raising Brave.

read more
Medical products

Brazil’s Viveo to Acquire 3 Medical Products Companies in Expansion Spurt

SAO PAULO, April 12 (Reuters)Brazilian distributor of medicines and medical products Viveo VVEO3.SA has reached an agreement to acquire three companies for a total of 365.5 million reais ($77.86 million) as it pushes for expansion, it said in a securities filing on Tuesday.

The deal includes parenteral nutrition company FAMAP, a supplier of sterile solutions and a distributor of hospital PHD products, Viveo – formerly known as CM Hospitalar SA – said.

Life and FAMAP combined accounted for 58 million reais of earnings before interest, taxes, depreciation and amortization (EBITDA), while PHD is expected to add 17.5 million reais of EBITDA, Viveo added.

Life and PHD are based in the southern city of Porto Alegre, and FAMAP is headquartered in Belo Horizonte. The deal still requires approval from Brazilian antitrust watchdog CADE.

The move comes less than a year after Viveo and its shareholders raised R$2.32 billion in an initial public offering (IPO) that valued the company at R$5.7 billion at the time.

($1 = 4.6944 reais)

(Reporting by Gabriel Araujo; editing by Jason Neely)

(([email protected]; +55 11 5644 7745;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

read more
Generic drugs

Repurposing generic drugs can reduce the time and cost of developing new treatments

Discovering new ways to use existing drugs can happen intentionally or by chance.

Sometimes doctors or patients notice an unexpected beneficial effect of a drug. An example is sildenafil, a drug originally developed to treat severe chest pain caused by coronary heart disease. Although sildenafil failed in clinical trials, researchers noticed that one of its side effects was the induction of erections. This led to its successful rebranding as erectile dysfunction drug Viagra.

Most of the time, when drugs are reused for diseases or conditions for which they were not originally intended, it is done deliberately. As scientists raced to develop treatments for COVID-19, drug redirection has come into the spotlight for good and bad reasons.

As a researcher focused on drug discovery and development, I have seen the potential for redirection and the challenges it faces. Although finding new uses for drugs that have already been tested and approved for safety by the FDA can dramatically reduce development time and cost, financial and logistical hurdles can make it difficult to get to market.

The success of thalidomide

When the redirection is successful, a drug that is ineffective or harmful for one condition can save the life of others.

One such drug is thalidomide, first approved as a treatment for morning sickness. It rose to prominence in the late 1950s when it caused birth defects in an estimated 10,000 infants worldwide, leading to regulatory and drug development changes that included increased developmental toxicity testing . Thalidomide was banned globally in the late 1960s.

In the 1990s, however, researchers discovered that thalidomide inhibits angiogenesis, or the growth of new blood vessels that supply nutrients and oxygen to tumors. Its new use as a treatment for a blood cancer called multiple myeloma has finally achieved clinical and commercial success. This has led to the development of improved versions of the drug that treat cancer with reduced side effects.

The reuse of generic drugs could offer a cheaper and faster way to develop new treatments.

Scientists continued to find other therapeutic uses for thalidomide.

When researchers discovered that thalidomide targets a molecule in the body that marks other proteins for destruction, they exploited this feature in an emerging technology called PROTAC. Many drugs work in the body by inhibiting a particular target that produces an adverse effect, usually reversibly and temporarily. PROTACs, on the other hand, are a type of drug that can completely destroy the target. This potentially increases the effectiveness of the drug and reduces the risk of drug resistance.

An example is bavdegalutamide, a PROTAC that combines thalidomide with an inhibitor typically used to treat prostate cancer. This inhibitor works by blocking a target that supplies the tumor with hormones that help it grow. An ongoing phase 2 clinical trial of bavdegalutamide is based on the idea that killing the target would cut off the hormone supply to tumors and stop their growth more effectively than conventional inhibitors.

Researchers currently produce PROTACS often by repurposing existing drugs. With promising results underway, 2021 has seen the launch of a wave of clinical trials testing PROTACs as a treatment for a number of different cancers.

Reassignment for COVID-19

Researchers have used a myriad of drug redirection approaches during the COVID-19 pandemic, ranging from educated guesses to large-scale drug screening and data mining from millions of electronic health records. Regardless of how researchers decide which drugs to reuse, all candidates must demonstrate strong clinical benefit in people before they can be cleared or approved for any proposed new use by the FDA.

My research team and I tested 1,425 FDA-approved drugs in human cells infected with COVID-19 and found 17 candidates for redirection for further investigation. Several of the leads we identified have since entered early clinical trials, including drugs originally intended to treat leprosy and prostate cancer, as well as a milk-derived supplement.

Redirecting drugs could help expand treatment options for various illnesses, including COVID-19. smartboy10/DigitalVision Vectors via Getty Images

Researchers launched hundreds of clinical studies early in the pandemic to test drug redirection candidates for COVID-19. There have been some notable successes, including the generic antidepressant fluvoxamine, which reduced the risk of hospitalization by 32% in a clinical study. A meta-analysis of fluvoxamine and two other COVID-19 antiviral drugs, molnupiravir and Paxlovid, found that they all provided protective benefits against COVID-19 with comparable safety profiles.

Unlike these newer COVID-19 antivirals, however, fluvoxamine has a 40-year track record of safely treating depression and obsessive-compulsive disorder. Despite this, fluvoxamine has not been cleared for emergency use by the FDA, and the National Institutes of Health says there is insufficient evidence for its use against COVID-19.

The Challenges of Drug Discovery

Successful drug repurposing highlights the difficulty of predicting the off-target effects of new treatments.

Eflornithine, for example, is a drug that has been shown to be ineffective against cancer – but it turns out to inhibit facial hair growth in women and cure a parasitic infection called trypanosomiasis or sleeping sickness. It’s often not immediately obvious why a drug would effectively treat two seemingly different health conditions like these.

There are approximately 2,500 drugs approved by the FDA, and an average of 46 new drugs are approved each year. However, more than 90% of drugs that enter clinical trials fail. This percentage rises to 97% for cancer drugs. Although many shots are needed to produce a viable drug, each failed drug is a candidate for reuse. Researchers like me collected these “failed” compounds for further testing, combing through research papers, patents, and clinical trial databases to find candidates for reuse. Some labs have used artificial intelligence to automate this process.

But it can be difficult to determine which drugs are available for reuse. While a drug development database suggests that there are 47,000 compounds already tested ready for re-use, there is no central repository for this information.

Marketing Landscape

Drug reuse comes up against an intellectual property barrier. Reuse is more accessible with generic drugs that do not have patents limiting their use for other conditions. But there are fewer opportunities for profit with generics than with new drugs.

Patents allow drug suppliers to have a sales monopoly for a period of time. Repurposed drugs typically receive “use patents” that protect the use of an existing drug for a particular new disease. But companies see this kind of protection as less valuable than a “composition of matter” patent that restricts drug sales to patent holders only. An FDA analysis found that a drug with two drug suppliers resulted in an average price reduction of 39%, and six or more suppliers resulted in a 95% reduction. With less patent protection on a drug, more competitors can enter the market and manufacturers make less money.

Because of this perceived lack of market potential, drug repurposing is typically left to academic institutions that lack the resources to obtain new or repurposed drugs through the costly approval process.

It’s possible that if fluvoxamine was a new drug in development with patent protection at a major pharmaceutical company, it would have already obtained FDA approval to treat COVID-19. But as it stands, fluvoxamine is a widely available generic that any doctor can prescribe “off-label” to treat conditions that haven’t been approved by the FDA, such as COVID-19.

This leads to a tragedy of the commons in which no company will invest in the clinical trials needed to bring a repurposed drug to market, because the resulting benefits would be immediately shared with all competitors.

Bringing a new drug to market is a long and expensive process with a high failure rate. When the pharmaceutical industry cannot justify the development of a new drug due to low return on investment, drug repurposing can fill the void. Federal support could make repurposing more commercially attractive, incentivizing companies to enter the market and boosting this cost-effective way to address unmet medical needs.

This article is republished from The Conversation under a Creative Commons license. Read the original article.

read more
Medical products

Veress Needle Market Size, Trends and Forecasts

New Jersey, United States – Verified Market Research provides an encyclopedic study of Veress needle market with holistic information about important factors and aspects impacting the future growth of the market. The Veress Needles Market has been analyzed for the forecast period 2022-2029 and the historical period 2015-2021. To assist players to gain thorough understanding of the Veress Needles Market and its critical dynamics, the research study provides detailed qualitative and quantitative analysis. Additionally, readers are offered comprehensive and in-depth research on various regions and segments of the Veress Needle market. Almost all industry-specific microeconomic and macroeconomic factors affecting the growth of the global market have been analyzed in the report.

With a comprehensive analysis of the competitive landscape, the authors of the Veress Needle Market report have made a brilliant attempt to study the key developments, pricing and business-related tactics as well as the future plans of the major companies. Along with the Players Veress Needle Market performance in terms of revenue and revenue, analysts shed light on their production, areas served, gross margin, and other important factors. Moreover, Veress Needle report helps players to gain an upper hand in market competition by thoroughly analyzing the market positioning, market growth, and product portfolio of its competitors.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=212073

Key Players Mentioned in the Veress Needle Market Research Report:

CONMED, Fairmont Medical Products Pty Ltd, GRI-Alleset, Grena Ltd., 3-Dmed, Advin Health Care, Changzhou Ankang Medical Instruments Co., Ltd., Duomed Group, Endomed Systems GmbH, Zhejiang Geyi Medical Instrument Co., Ltd. , LOCAMED LIMITED.

Segmentation of the Veress needle market:

Veress Needles Market, By Type

• 120mm
• 150mm
• Others

Veress Needles Market, By Application

• Gynecological surgery
• Urological surgery
• General surgery

The report is the best compilation of different types of segmental analyzes of the Veress Needle market done from different perspectives. The analysts’ pragmatic approach to studying different market segments and top-down and bottom-up approaches to forecasting the size of their markets makes the Veress Needle study unique and accurate. Reliable primary sources such as CTOs, Physicians, VPs, CEOs, and supply and demand side industry experts were consulted to validate and revalidate the market and market figures. ‘other information. Secondary sources such as Bloomberg, databases, white papers, press releases and company reports were used to collect market information and data.

This research study can be used by all participants of the Veress Needle market as it covers all the major and minor aspects of the current and future competition in the market. It can also prove to be very beneficial for the stakeholders given the training offered and a detailed analysis of the growth strategies expected from the players in the coming years. Newcomers or players who want to make a foray into the Veress Needle market can get useful insights and effective guides from the report. On the other hand, established companies can use the Veress Needle report to keep themselves informed about current and future market scenarios and to plan their future business moves.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=212073

Scope of the Veress Needles Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

Determining the pulse of the market becomes easy with this detailed analysis of the Veress Needle market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the Veress Needle market?

2. How will the Veress needle market evolve over the next five years?

3. Which product and which application will take the lion’s share of the Veress needle market?

4. What are the drivers and restraints of the Veress Needle Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Veress Needle market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/veress-needle-market/

Visualize the Veress Needle Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Veress needle market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Women’s Health Rehabilitation Products Market Size, Trends and Forecasts

New Jersey, United States – Verified Market Research provides an encyclopedic study of Women’s Health Rehabilitation Products Market with holistic information about important factors and aspects impacting the future growth of the market. The Women’s Health Rehabilitation Products Market has been analyzed for the forecast period 2022-2029 and the historical period 2015-2021. To assist players to gain thorough understanding of the Women’s Health Rehabilitation Products market and its critical dynamics, the research study provides detailed qualitative and quantitative analysis. Additionally, readers are offered comprehensive and in-depth research on various regions and segments of the Women’s Health Rehabilitation Products market. Almost all industry-specific microeconomic and macroeconomic factors affecting the growth of the global market have been analyzed in the report.

With a comprehensive analysis of the competitive landscape, the authors of the Women’s Health Rehabilitation Products market report have made a brilliant attempt to study the key developments, pricing and business tactics as well as the future plans of major companies. . Along with the Players Women Health Rehabilitation Products market performance in terms of revenue and revenue, the analysts shed light on their production, areas served, gross margin, and other important factors. Moreover, the Women’s Health Rehabilitation Products report helps players to gain an upper hand in the market competition by thoroughly analyzing the market positioning, market growth, and product portfolio of its competitors.

Get Sample Full PDF Copy of Report: (Including Full Table of Contents, List of Tables and Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=22158

Key Players Mentioned in the Women’s Health Rehabilitation Products Market Research Report:

Accord Medical Products, BSN medical, Carib Rehab, Cornerstone Chiropractic, DeRoyal, EMS Physio, GE Healthcare, GPC Medical, Meyer Physical Therapy, Midtown Chiropractic, PROSPINE Health and Injury Center, Pelvic Health and Rehabilitation, Pure Health Chiropractic, Sportstek, Win Health Medical, Zynex

Women’s Health Rehabilitation Products Market Segmentation:

Women’s Health Rehabilitation Products Market by Product

• Orthopedic care
• Urinary incontinence
• Breast cancer care
• Pregnancy and postpartum care

Women’s Health Rehabilitation Products Market By Application

• Hospitals
• Clinics

The report is the best compilation of different types of Women’s Health Rehabilitation Products market segmental analysis done from different perspectives. The analysts’ pragmatic approach to studying different market segments and top-down and bottom-up approaches to forecasting their market sizes makes the Women’s Health Rehabilitation Products research study unique and accurate. Reliable primary sources such as CTOs, Physicians, VPs, CEOs, and supply and demand side industry experts were consulted to validate and revalidate the market and market figures. ‘other information. Secondary sources such as Bloomberg, databases, white papers, press releases and company reports were used to collect market information and data.

This research study can be utilized by all participants of the Women’s Health Rehabilitation Products market as it covers all the major and minor aspects of the current and future market competition. It can also prove to be very beneficial for the stakeholders given the training offered and a detailed analysis of the growth strategies expected from the players in the coming years. Newcomers or players who want to foray into the Women’s Health Rehabilitation Products market can get helpful insights and efficient guides from the report. On the other hand, established businesses can use the Women’s Health Rehabilitation Products report to keep themselves informed with current and future market scenarios and to plan their future business moves.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=22158

Scope of the Women’s Health Rehabilitation Products Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the Women’s Health Rehabilitation Products Market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the Women’s Health Rehabilitation Products Market?

2. How will the women’s health rehabilitation products market develop in the next five years?

3. Which product and application will occupy the lion’s share of the women’s health rehabilitation products market?

4. What are the drivers and restraints of the Women’s Health Rehabilitation Products Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Women’s Health Rehabilitation Products market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/women-health-rehabilitation-products-market/

Visualize Women’s Health Rehabilitation Products Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Women’s Health Rehabilitation Products Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical supplies

San Diego couple travel to Ukraine to deliver medical supplies – NBC 7 San Diego

As war continues to force families from their homes in Ukraine, families in San Diego continue to help.

Nadia and Askold Haywas boarded a plane last week, taking several bags of donated medical supplies with them. They landed in Warsaw, Poland and then traveled to Lviv, Ukraine.

On Sunday, Nadia Haywas spoke with NBC 7 about their experience.

“It’s easier to take it ourselves because we’re here in 10 hours,” Haywas said.

Haywas explained that it was faster and more efficient than shipping the items. Once in the field, they can hand off supplies directly to organizations they know will send items to the frontlines or where they are needed most.

“Tourniquets save lives…we need tourniquets that don’t break,” she said.

Lviv has suffered some brutal attacks in recent weeks, although Haywas says it is safer than eastern Ukraine, where most of the devastation and fighting is taking place. They always take precautions when leaving their accommodation.

“We try not to go where there’s a big crowd,” she said.

This weekend, they went to a station where refugees from the East are arriving in large numbers.

“Everyone is traumatised, whether they lived through a bombing and had to leave their house or are here accepting refugees,” she said.

They currently live with her husband’s family who live in Lviv – grateful to be united with them in safety.

“We couldn’t both stay home and not see them… not knowing when this war was going to end and if we were ever going to be able to see them again.

Hayward says the need for humanitarian and medical assistance is overwhelming. She is proud of the outpouring of support from San Diegans.

“We couldn’t have provided this help without the generosity of the people of San Diego.”

She added that one of the best ways people can continue to help is to make a financial donation to Ukraine House, as it allows them to buy the supplies they need in bulk to send to the stranger. You can donate by visiting their website here.

read more
Medical products

Personal Mobility Devices Market Size, Trends and Forecasts

New Jersey, United States – Verified Market Research provides an encyclopedic study of personal mobility device market with holistic information about important factors and aspects impacting the future growth of the market. The Personal Mobility Devices Market has been analyzed for the forecast period 2022-2029 and the historical period 2015-2021. To assist players to gain a thorough understanding of the Personal Mobility Devices market and its critical dynamics, the research study provides detailed qualitative and quantitative analysis. Additionally, readers are offered comprehensive and in-depth research on various regions and segments of the Personal Mobility Devices market. Almost all industry-specific microeconomic and macroeconomic factors affecting the growth of the global market have been analyzed in the report.

With a comprehensive analysis of the competitive landscape, the authors of the Personal Mobility Devices market report have made a brilliant attempt to study the key developments, pricing and business-related tactics as well as the future plans of leading companies. Along with Players Personal Mobility Devices market performance in terms of revenue and revenue, analysts shed light on their production, areas served, gross margin and other important factors. Moreover, the Personal Mobility Devices report helps players to gain an upper hand in the market competition by thoroughly analyzing the market positioning, market growth, and product portfolio of its competitors.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=37564

Key Players Mentioned in the Personal Mobility Devices Market Research Report:

NOVA Medical Products, Performance Health, Drive DeVilbiss Healthcare, Medline Industries Invacare Corporation, Carex Health Brands Kaye Products Rollz International, GF HEALTH PRODUCTS and Briggs Healthcare

Personal Mobility Devices Market Segmentation:

Personal Mobility Devices Market, By Product

• Wheel chairs
• Scooters
• Walking aids

The report is the best compilation of different types of segmental analyzes of the Personal Mobility Devices Market performed from different perspectives. The analysts’ pragmatic approach to studying different market segments and top-down and bottom-up approaches to forecasting the size of their markets makes the Personal Mobility Devices research study unique and accurate. Reliable primary sources such as CTOs, Physicians, VPs, CEOs, and supply and demand side industry experts were consulted to validate and revalidate the market and market figures. ‘other information. Secondary sources such as Bloomberg, databases, white papers, press releases and company reports were used to collect market information and data.

This research study can be used by all participants of the Personal Mobility Devices market as it covers all the major and minor aspects of the current and future competition in the market. It can also prove to be very beneficial for the stakeholders given the training offered and a detailed analysis of the growth strategies expected from the players in the coming years. Newcomers or players who want to make a foray into the Personal Mobility Devices market can get useful insights and effective guides from the report. On the other hand, established businesses can use the Personal Mobility Devices report to keep themselves informed with current and future market scenarios and to plan their future business moves.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=37564

Scope of the Personal Mobility Devices Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the Personal Mobility Devices market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the personal mobility device market?

2. How will the personal mobility device market evolve in the next five years?

3. Which products and applications will capture the lion’s share of the personal mobility device market?

4. What are the drivers and restraints of the Personal Mobility Devices Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Personal Mobility Devices market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/personal-mobility-devices-market/

Visualize the Personal Mobility Devices Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Personal Mobility Devices Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and gas. Etc.

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical supplies

Medical supplies collected in Middletown for first responders in Ukraine – NBC Connecticut

Community spirit goes international with Ukrainian firefighters’ equipment drive in Middletown this weekend.

Organized by the South Fire District of Middletown and co-sponsored by six organizations, the goal is to collect firefighting equipment and medical supplies in Connecticut to send to Ukraine to help firefighters fight on the front lines.

“I could see the buildings in the background burning and bombing and I knew the firefighters were stressed and that’s exactly why I wanted to organize the supply drive,” said Gary Wallace, director of Community Health Center Inc.

Wallace, a campaign sponsor, said the idea was born during an online community meeting discussing creative ways the community could help.

“As a veteran, I just have knowledge and experience of what’s going on with trauma and retirement and things like that, so I contacted the Southern District Fire Department” , Wallace said.

And the district answered the call.

Chief Trzaki describes the packages that have flocked and said that there are still items that are needed.

“They have dropped off goods and equipment, firefighting equipment – hand tools, personal protective equipment including helmets and boots and first aid supplies. We need first aid supplies We need durable first aid supplies, trauma bandages, needles, syringes for the front line,” said Southern District Fire Department Chief Jim Trzaski.

Items collected include painkillers, backpacks, bandages, first aid kits, medical gloves, antibiotic ointments, water-gel burn aids, compression bandages, medical tape, eyewash stations, CPR masks and safety glasses.

Dr. Katja Kolcio is a Wesleyan University professor who is not only a sponsor, but has been doing humanitarian work in Ukraine for almost 10 years. She said the items collected during the collection will make a difference.

“Equipment, bodyboards, fire protection equipment, medical supplies, they are just not available in Ukraine or surrounding countries anymore. I think that is what they need more than anything There is not a single place in Ukraine that is safe. They need these supplies more than anything,” Kolcio said.

Trzaski had a message for firefighters in Ukraine.

“We just hope this helps in the least bit and our hearts go out to you and you are the bravest firefighters we have ever seen,” Trzaski said.

The campaign will continue Sunday, April 10 from 8 a.m. to 4 p.m. at the Southern District Fire Department.

read more
Prescription drugs

Anti-Obesity Prescription Drugs Market Size 2022, Growth Trends, Covid-19 Economic Impact Analysis

Anti-Obesity Prescription Drugs Market Size 2022 Growth Development Trends, Global Economy Covid-19 Impact Analysis and 2031 Forecast

The Anti-Obesity Prescription Drugs Market is estimated to register a CAGR of XX% in terms of value during the forecast period 2022-2031. The report offers in-depth insights, revenue details and other vital information regarding the target market along with the various trends, drivers, restraints, opportunities and threats till 2031. The report offers insightful and in-depth information about the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments except future strategies, acquisitions & mergers, and market footprint . The Anti-Obesity Prescription Drugs Market report has been segmented on the basis of product, type, end-user and region.

The current possibilities of the prescription obesity drugs market in the sector have also been analyzed. Additionally, major strategic activities in the market, which incorporate product advancements, acquisitions, and partnerships, are discussed. Anti-Obesity Drugs Market Organization Coverage (Company Profile, Revenue, Price, Gross Margin, Major Products etc.)

>> Get a sample PDF of the report: https://marketresearch.biz/report/anti-obesity-prescription-drugs-market/request-sample/

Competitive market players are identified along with their size, share, and strategies. The company profiles of these players include their recent major developments, product portfolio, revenue, core competencies, and financials. In addition, the report presents information on mergers and acquisitions, company profiles, financial status, product portfolio and SWOT analysis.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities and restraints that may change the market dynamics of the industry. It provides an in-depth analysis of market segments which includes products, applications, and competitor analysis.

• Key players in the anti-obesity prescription drugs market:

  • Bristol-Myers Squibb Co.
  • Takeda Pharmaceutical Company Ltd.
  • Eisai Co., Ltd.
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Shionogi USA, Inc.
  • Vivu Inc.
  • Zafgen Inc.
  • Norgine B.V.
  • Boehringer Ingelheim GmbH.

Key Segments Covered

Global Prescription Anti-Obesity Drugs Market Segmentation by Mechanism of Action:

  • Incretin mimetics/GLP-1 agonists
  • SNDRI
  • Lipase inhibitors
  • Serotonin receptor agonists
  • Sympathomimetic GABA receptor agonists
  • Sympathomimetics
  • Others (human Glucagon-like peptide-1 analog, dopamine and norepinephrine inhibitors, etc.)

Global Prescription Anti-Obesity Drugs Market Segmentation By Target Location:

  • Peripherally acting anti-obesity drugs
  • Centrally acting anti-obesity drugs

Global Prescription Anti-Obesity Drugs Market Segmentation By Therapy:

  • Monotherapies
  • Polytherapies

Global Prescription Anti-Obesity Drugs Market Segmentation, By Distribution Channel:

  • Hospital
  • Clinics
  • Pharmacies

Covid-19 scenario

Manufacturing activities are hampered due to containment measures put in place by governments of various countries. Additionally, the supply chain has been disrupted and raw material shortages have occurred.

Demand from application industries such as textiles, ceramics and glass has declined due to disruptions in day-to-day operations. However, demand would steadily increase during post-lockdown as day-to-day operations resume.

>> We provide COVID 19 Impact Analysis on Anti-Obesity Prescription Drugs Market, for more details, please click on the link: https://marketresearch.biz/report/anti-obesity-prescription-drugs -market/covid-19-impact/

Research objectives:

• The Prescription Anti-Obesity Drugs Market report provides marketing type analysis, market supply chain analysis, international trade type analysis, and region-wise traders or distributors with their contact details.

• The Prescription Anti-Obesity Drugs Market report further focuses on the study of product capacity, product price, profit flow, supply/demand ratio, production, sales rate, market growth and projected growth forecasts.

• A comprehensive synopsis of major market events and developments in the Prescription Anti-Obesity Drugs market.

• The report tracks the key market players who will shape and have the greatest impact on the Prescription Anti-Obesity Drugs market.

• The report helps you understand the real effects of the major market drivers or restrainers on the Prescription Anti-Obesity Drugs market activities.

• The Anti-Obesity Prescription Drugs Market report offers statistical data in terms of value (USD) as well as volume (units) till 2031.

• The information contained in the Prescription Anti-Obesity Drugs Market report can be easily understood and contains graphical representation of the figures in the form of bar graphs, statistics, and pie charts etc.

• It includes a vast amount of information on the latest technologies and product developments in the anti-obesity prescription drug market industry.

• Company strategies related to the growth of the anti-obesity prescription drug market.

https://marketresearch.biz/report/anti-obesity-prescription-drugs-market/#inquiry

Global Prescription Anti-Obesity Drugs Market Details Based on Regions:

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, Nigeria and South Africa)
  • Central and South America (Brazil, Argentina, Colombia, etc.)

Key topics covered in the table of contents:

Chapter 1- Report Overview: Includes key players from entire Secure Van market as part of the test, scope of the study

Chapter 2- This section focuses on industry trends where determined market drivers and elevated market patterns. It also provides development milestones for key developers working within Global Pickup Truck Market. Additionally, it provides inception and limitation of tests while developing measurement, limit, creativity, and creative prediction models of the Anti-Obesity Drugs Market.

Chapter 3-
This clip focuses on the types of items whose creation examines the overall business size, cost, and overall business structure based on the type of item discussed, providing an in-depth overall application of the Drugs Market anti-obesity prescription.

Chapter 4- Here, a combination of the right pace of development, development and onboarding, and key players in each local market is provided.

Chapter 5- This section provides usage data for each local market based on the report. Use tested if country, application and product type are possible.

Chapter 6- Organizational Profiles: Numerous players driving the entire Anti-Obesity Drugs Market are imprinted in this section. Auditors provided data on their continuous development within the global van market, materials, income, creativity, business, and friends.

Chapter 7- The collection and construction estimates included in this section add up to the value of the pickup truck market in addition to the major business categories.

Chapter 8- Forecast consumption of the market: consumption rate and consumption included in this section

Chapter 9- Value Chain and Sales Analysis: An in-depth analysis of customers, retailers, channels of transactions, and major Vans Market Series in general.

>> Get detailed TOC including data, facts, figures, tables etc here: https://marketresearch.biz/report/anti-obesity-prescription-drugs-market/#toc

• Contact us:-

For any questions:- [email protected]

MarketResearch.Biz (powered by Prudour Pvt. Ltd.)

420 Lexington Avenue, Suite 300

New York, NY 10170

United States

Phone: +1 (347) 796-4335

Website: https://marketresearch.biz

Email ID: [email protected]

Get customization in the report as per your business requirement: https://marketresearch.biz/report/anti-obesity-prescription-drugs-market/#request-for-customization

About Us:-

Marketresearch.biz is a market research, analysis and solutions company, providing strategic and tactical support to clients to make informed business decisions. We are a team of dedicated and passionate people who strongly believe in bringing our best to what we do and we never back down from a challenge. We provide coverage, analysis, information, statistics and reports on global and regional markets, industries, sectors and areas, including Pharmaceuticals, Chemicals and Materials, Technology and Media , food and beverage, packaging and consumer goods, among others. .

© Scoop Media

read more
Medical products

FDA Releases Draft MDUFA V 2023 – Medical Product Supply Chain Week in Review | Alston and bird

Over the past few weeks, the FDA has continued to focus its attention on supply chain issues. The agency has released draft guidance on the expectations of its supply chain business partner verification system for prescription drugs and a draft of what manufacturers can expect in changes to drug fees. Device Use (MDUFA V) 2023. The Center for Devices and Radiological Health (CDRH) has released a fact sheet to inform the public of its plans to prevent future medical device shortages. The FDA has submitted its 2023 budget to Congress. In a similar vein, the FDA updated its device shortage and discontinuation list and sent a letter to medical personnel detailing retention strategies. Representatives Mike Gallagher (R-WI) and Mark Pocan (D-WI) introduced a bill in an effort to strengthen the supply chain for medical products. In other developments, investments continue to be made in cold chain monitoring as consumer lifestyles and habits change. Please see details of these and other supply chain developments below:

  • On March 10, the FDA published draft guidance on agency expectations of drug supply chain business partners, “Verification Systems Under the Drug Supply Chain Security Act for Certain Prescription Drugs.” These follow-up guidelines clarify the expectations of manufacturers, repackers, wholesale distributors and dispensers to prepare for the implementation of Section 202 of the Security of the Medicines Supply Chain Act of 2013. Specifically, the draft guidance focuses on expectations of system requirements and what system activities it expects to see from each supply chain trading partner. Emphasis is placed on what is necessary to ensure adequate assessment processes for suspect and illegitimate products to either release them to market or safely remove them from the supply chain to prevent future distribution.
  • On March 17, the FDA published a fact sheet, “Mitigate and Prevent Medical Device Shortages and Prioritize Public Health,” designed to inform the public of the steps CDRH is taking to prevent future device shortages. Under the authority granted by the CARES Act, the FDA worked with manufacturers and other entities to expedite the review of device submissions and address supply chain vulnerabilities. Going forward, the FDA is seeking legislation requiring manufacturers to notify the agency of impending shortages, whether or not a public health emergency exists.
  • On March 21, the FDA added 0.9% sodium chloride IV lock/flush prefilled syringes (product code NGT – saline, vascular access flush) to the appliance shortage list and the device abandon list. The FDA has issued a Letter to health personnel provide recommendations, including storage strategies, for syringes. The FDA has also added certain discontinued surgical garments (product codes FME, FXP, FYF, LYU, and OEA) to the device discontinuation list.
  • On March 23, the FDA published the draft MDUFA V 2023, which outlines the responsibilities FDA commits to for manufacturers of medical products that require oversight. The agency plans to hire additional staff to facilitate compliance. Timelines attempt to manage expectations of increased submissions by providing timelines in which the agency will respond with the appropriate next step. The shared results objectives are:
    • Average total decision time for premarket approval submissions and panel pathway supplements of 290 and 285 calendar days for fiscal year 2023-2024 and for years 2025-2027, respectively.
    • For 510(k) submissions, the shared outcome targets are total decision time of 118 days for fiscal year 2023, 124 days for fiscal year 2024, and 112 days for years 2025-2027.
    • The FDA will also continue the Q-Submission program, which allows for pre-submission meetings with the agency for feedback. The FDA commits to a maximum response time of 15 calendar days for acceptability and 70 calendar days (or five before a meeting) for written comments.

    The terms of the agreement ask the FDA to commit to 90% timeliness for pre-submissions for FY2023 if the cohort is below 3,585 and 75% if the cohort is above (up to 4,300). For fiscal year 2024, the commitment is 90% for less than 4,060 and 80% for more (up to 4,300). For the years 2025 to 2027, the engagement target is 90% for a maximum of 4,300 pre-submissions. The specific objectives of the agency are stated in the letter.

  • On March 24, Rep. Mike Gallagher (R-WI), with Rep. Mark Pocan (D-WI) as co-sponsor, presented HR 7208, the Medical Supply Chain Security Act, which would amend federal food, drug and cosmetic law. As submitted, this bipartisan bill would require manufacturers to provide additional reporting on the supply and composition of drugs and medical devices and potential and impending shortages and allow expedited review of devices that traditionally require approval. prior to marketing. Manufacturers may be concerned about additional requirements that may increase the regulatory burden; however, the potential trade-off is the ability to more effectively market potential products considered life-saving. The bill was referred to the Energy and Commerce Committee.
  • On March 28, the FDA released its 2023 budget ask Congress. The application’s priorities indicate that the agency wants to increase its oversight power and is looking for ways to become more effective. Specifically, the FDA wants to require manufacturers to participate in remote interactive assessments and wants greater oversight to implement cybersecurity measures on devices, remove products from the market when no confirmatory data has been produced, removing barriers to competing generic drug approvals, overseeing dietary supplement ingredient lists, extending expiry dates for pharmaceutical products in the event of shortages, and ordering the destruction of imported products and payment for the action of destruction by manufacturers. The request also includes some elements relating to drug shortages. The agency is asking for the ability to require companies to report when a shortage of medical devices is expected and also to require companies to conduct risk assessments of their supply chain. It is expected that not all applications will be approved; however, they could be included in future legislation.
  • The FDA published its FY 2021 Medical Countermeasures Initiative (MCMi) program update. The objective of the program is to promote “the development of and access to safe and effective MCMs”. For fiscal year 2021, approximately 470 EUAs were issued for approximately 750 products. The agency has also approved, licensed, or cleared more than 1,000 generic drugs and about 500 PPE products. Additionally, in a signal that it intends to vigorously exercise its oversight authority, the FDA has identified approximately 1,500 fraudulent products. As a result, 260 warning letters were sent and 393 fraudulent test kits were reported. For this effort, the agency advises its partners in fiscal year 2021 that it has exercised its authority to “advance the FDA’s capabilities to monitor the MCM supply chain to identify product shortages and distribution of mislabelled/counterfeit products”.
  • Companies have been execution their own solutions for disruptions in the pharmaceutical supply chain. Three companies, Swoop Aero, Skyports and BD Rowa, have joined efforts to develop drone delivery systems for pharmaceuticals using healthcare technology solutions. Drone companies, Swoop Aero and Skyports, will provide the drone infrastructure. Swoop Aero has extensive mapping and video technology, and Skyports is developing vertiports for drone activities. BD Rowa will bring its automated technology to healthcare. The hope is that this joint venture can help eliminate touch points in the supply chain and improve efficiency and access to pharmaceuticals.
  • Consumption and consumer needs, including pharmaceuticals and farm-to-fork food trends, are driving demand for global monitoring of the cold chain, which encompasses the use of software and hardware to monitor refrigeration. It is estimated that by 2026, the market will reach $10.9 billion, driven largely by the United States and China, as companies invest in facilities and emerging technologies for their products. Growth is also visible in the Asia-Pacific region. With the expected growth, this is a business opportunity for manufacturers of software applications and hardware devices to grow and expand to meet incoming needs worldwide.

[View source.]

read more
Medical supplies

Medical Supplies Market Size, Growth and Forecast

New Jersey, United States – This Medical supplies market The report study provides detailed information on various industrial aspects such as techniques, models and major competitors operating in different districts. The examiners use step-by-step testing processes to provide perfect and essential information about the state and development of the market. It offers a comprehensive picture of prospective growth strategies, restraints, major competitors, previous periods, and market size by region and territory. The key market trend figures in the study are an excellent resource for businesses. In addition to company profiles, production capabilities and cost along with value and product information, this Medical Supplies market study includes other important criteria. It also examines the market share of each organization over the predicted period.

This illustrative report on Medical Equipment Market also talks about the data updating technologies introduced in the market to help market players to enlarge the product portfolio and gain higher revenue from it. The constant introduction of new technologies and product offerings helps companies set long-term goals. Several new companies have entered the market and started pursuing new strategies, upcoming contracts and new developments to regulate the global market and prove their position.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=144345

The Medical Supplies Market research report contains all essential and relevant market data useful to market players, including the latest market trends, competitive analysis, and customer behavior. It offers a number of advantages. It provides industry data, helps compare products to competitors’ products, analyzes results, implements additional analysis and data collection, and identifies target consumers. Conducting a market analysis provides a lot of information to learn about the level of competition in the market and customer preferences over new products or services. With this Medical Supplies Market report, it becomes easy to know more about the strategic mistakes made by other competitors in terms of product launches.

Key Players Mentioned in the Medical Supplies Market Research Report:

Johnson & Johnson, Coloplast Group, Fresenius Medical care AG & Co. KGaA, Teleflex Incorporated, Terumo Japan, Stryker, Merit Medical Systems, Cook Medical, Abbott ConvaTec Group Plc.

By knowing the upcoming market conditions for the estimation period 2022-2029, key players can make calculated and informed decisions regarding location, pricing, promotion, and product launch. This Medical Supplies Market report also enables business players to understand the current industry scenario, spot new opportunities, and understand the future actions of competitors and how they are operating in the market.

Medical Supplies Market Segmentation:

Medical Supplies Market, By Type

• Individual protection equipment
• Disinfectants
• Intubation and ventilation supplies
• Infusion and injectable supplies
• Diagnostic supplies
• Others

Medical Supplies Market, By Application

• Cardiology
• Infection control
• Respiratory
• Radiology
• Wound care
• Others

Medical Supplies Market, By End User

• Hospitals
• Clinics/Doctors’ offices
• Others

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=144345

Scope of the Medical Supplies Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the medical supplies market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the medical supplies market?

2. How will the medical supplies market evolve over the next five years?

3. Which product and which application will occupy the lion’s share of the medical supplies market?

4. What are the drivers and restraints of Medical Supplies Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Medical Supplies market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/medical-supplies-market/

Visualize the Medical Supplies Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the medical supplies market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. etc

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Prescription drugs

Global Prescription Anti-Obesity Drugs Market 2022 Supply Chain Analysis, Structure, Industry Inspection and Forecast 2028 – Instant Interview

MarketQuest.biz worked with a simple and error-free report. From 2022 to 2028, our specialists have strived to give the best and the best achievable system structure overall Global anti-obesity prescription drugs market.

Raw numbers on market items are displayed in the outline area. Additionally, it talks about the activity of the overall Anti-Obesity Drugs market along with the volume and sizing of the market. The report is drafted in a simple and simple configuration to consider an organized assessment of the complex and generally scattered information of the market. The development and restriction fragment has also clarified the expected potential outcomes and limitations of the market. This part gives data on specialized advances, ongoing innovations and market opportunities expected in the near future.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketquest.biz/sample-request/111857

It gives an in-depth study of Anti-Obesity Prescription Drugs Market Share:

It gives in-depth study of Anti-Obesity Prescription Drugs Market Sections:

  • Hospitals Pharmacies
  • Retail pharmacies
  • E-commerce

Just take a look at the most important specialized cooperatives on the market:

  • F Hoffmann La Roche SA
  • Therapeutic Ordemanden
  • Novo Nordisk A/s
  • Arena Pharmaceuticals
  • Glaxosmithkline
  • Lived
  • Boehringer Ingelheim
  • Alizyme

His emphasis on investigating the local portion:

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
  • South America (Brazil, Argentina, Colombia and rest of South America)
  • Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, South Africa and Rest of Middle East and Africa)

ACCESS FULL REPORT: https://www.marketquest.biz/report/111857/global-anti-obesity-prescription-drugs-market-2022-by-manufacturers-regions-type-and-application-forecast-to-2028

The topographic survey area inspects the entirety of the places in the world which add to the extension of the global prescription anti-obesity drugs market. This segment provides data on volume, market size, and value of each domain to help our clients gain an upper hand in the global market.

Frequently Asked Questions

  • Which area will make striking commitments to Global Prescription Anti-Obesity Drugs Market revenue?
  • What are the key elements driving the Prescription Anti-Obesity Drugs market?
  • What will be the value of the Prescription Anti-Obesity Drugs Market in 2022-2028?
  • Who are the essential players utilizing the Prescription Anti-Obesity Drugs market development?

Report customization:

This report can be customized to meet customer requirements. Please contact our sales team ([email protected]), who will ensure that you get a report tailored to your needs. You can also get in touch with our executives at +1-201-465-4211 to share your research needs.

Contact us
mark the stone
Business Development Manager
Call: +1-201-465-4211
E-mail: [email protected]

read more
Prescription drugs

Schuyler County Sheriff’s Office will take back unwanted prescription drugs

The Schuyler County Sheriff’s Office and the Schuyler County Coalition on Underage Drinking and Drugs (SCCUDD) are encouraging community members to participate in National Medication Take Back Day on Saturday, April 30, 2022. Community members can drop their expired, unused or unwanted medications. medication between 10 a.m. and 2 p.m. at the Odessa and Tyrone fire departments. The Odessa Fire Department is located at 300 East Main Street. The Tyrone Fire Department is located at 3600 State Route 226.

This initiative, organized by the Drug Enforcement Administration (DEA), addresses a vital public safety and public health issue. Pills left unused in homes can easily end up being abused by someone or accidentally taken by a child. The rates of prescription drug abuse in the United States are alarming, as are the number of accidental poisonings and overdoses due to these drugs. The Substance Abuse and Mental Health Services Administration’s National Drug Use and Health Survey shows year after year that the majority of misused and abused prescription drugs are obtained from family and friends, including someone else’s medication stolen from the medicine cabinet at home. Additionally, Americans are now being told that their usual methods of disposing of unused medications – flushing them down the toilet or tossing them in the trash – both pose potential safety and health risks.

Community members can also dispose of unwanted, expired, and unused prescription medications year-round by using the confidential drop boxes available 24/7 at the Schuyler County Sheriff’s Office ( 607-535-8222) in Watkins Glen or in the foyer of the Human Services Complex in Montour Falls.

SCCUDD is a group of dedicated community members, businesses, and agencies working to prevent, reduce, and delay the onset of substance use among Schuyler County youth by collaborating with our community partners, promoting prevention education and substance-free activities; and implementing environmental measures strategies. The SCCUDD works to reduce the use of alcohol, tobacco and other drugs among young people because they can cause lifelong problems. SCCUDD’s vision is a connected community where young people have education, resources, and drug-free options to help them grow into happy, healthy adults.

For more information or to get involved with SCCUDD, visit SCCUDD online or follow SCCUDD on Facebook, Twitter and Instagram.


Get the latest headlines delivered to your inbox every morning. Sign up for our morning edition to start your day. FL1 on the way! Download the free FingerLakes1.com app for Android (all Android devices) or iOS (iPhone, iPad).


read more
Generic drugs

Repurposing generic drugs can reduce the time and cost of developing new treatments, but low cost-effectiveness remains a barrier

Discovering new ways to use existing drugs can happen intentionally or by chance.

Sometimes doctors or patients notice an unexpected beneficial effect of a drug. An example is sildenafil, a drug originally developed to treat severe chest pain caused by coronary heart disease. Although sildenafil failed in clinical trials, researchers noticed that one of its side effects was the induction of erections. This led to its successful rebranding as erectile dysfunction drug Viagra.

Most of the time, when drugs are reused for diseases or conditions for which they were not originally intended, it is done deliberately. As scientists raced to develop treatments for COVID-19, drug redirection has come into the spotlight for good and bad reasons.

As a researcher focused on drug discovery and development, I have seen the potential for redirection and the challenges it faces. Although finding new uses for drugs that have already been tested and approved for safety by the FDA can dramatically reduce development time and cost, financial and logistical hurdles can make it difficult to get to market.

The success of thalidomide

When the redirection is successful, a drug that is ineffective or harmful for one condition can save the life of others.

One such drug is thalidomide, first approved as a treatment for morning sickness. It gained notoriety in the late 1950s when it caused birth defects in an estimated 10,000 infants worldwide, leading to regulatory and drug development changes that included increased developmental toxicity testing . Thalidomide was banned globally in the late 1960s.

In the 1990s, however, researchers discovered that thalidomide inhibits angiogenesis, or the growth of new blood vessels that supply nutrients and oxygen to tumors. Its new use as a treatment for a blood cancer called multiple myeloma has finally achieved clinical and commercial success. This has led to the development of improved versions of the drug that treat cancer with reduced side effects.

The reuse of generic drugs could offer a cheaper and faster way to develop new treatments.

Scientists continued to find other therapeutic uses for thalidomide.

When researchers discovered that thalidomide targets a molecule in the body that marks other proteins for destruction, they exploited this feature in an emerging technology called PROTAC. Many drugs work in the body by inhibiting a particular target that produces an adverse effect, usually reversibly and temporarily. PROTACs, on the other hand, are a type of drug that can completely destroy the target. This potentially increases the effectiveness of the drug and reduces the risk of drug resistance.

An example is bavdegalutamide, a PROTAC that combines thalidomide with an inhibitor typically used to treat prostate cancer. This inhibitor works by blocking a target that supplies the tumor with hormones that help it grow. An ongoing phase 2 clinical trial of bavdegalutamide is based on the idea that killing the target would cut off the hormone supply to tumors and stop their growth more effectively than conventional inhibitors.

Researchers currently produce PROTACS often by repurposing existing drugs. With promising results underway, 2021 has seen the launch of a wave of clinical trials testing PROTACs as a treatment for a number of different cancers.

Reassignment for COVID-19

Researchers have used a myriad of drug redirection approaches during the COVID-19 pandemic, ranging from educated guesses to large-scale drug screening and data mining from millions of electronic health records. Regardless of how researchers decide which drugs to reuse, all candidates must demonstrate strong clinical benefit in people before they can be cleared or approved for any proposed new use by the FDA.

My research team and I tested 1,425 FDA-approved drugs in human cells infected with COVID-19 and found 17 candidates for redirection for further investigation. Several of the leads we identified have since entered early clinical trials, including drugs originally intended to treat leprosy and prostate cancer, as well as a milk-derived supplement.

Redirecting drugs could help expand treatment options for various illnesses, including COVID-19.
smartboy10/DigitalVision Vectors via Getty Images

Researchers launched hundreds of clinical studies early in the pandemic to test drug redirection candidates for COVID-19. There have been some notable successes, including the generic antidepressant fluvoxamine, which reduced the risk of hospitalization by 32% in a clinical study. A meta-analysis of fluvoxamine and two other COVID-19 antiviral drugs, molnupiravir and Paxlovid, found that they all provided protective benefits against COVID-19 with comparable safety profiles.

Unlike these newer COVID-19 antivirals, however, fluvoxamine has a 40-year track record of safely treating depression and obsessive-compulsive disorder. Despite this, fluvoxamine has not been cleared for emergency use by the FDA, and the National Institutes of Health says there is insufficient evidence for its use against COVID-19.

The Challenges of Drug Discovery

Successful drug repurposing highlights the difficulty of predicting the off-target effects of new treatments.

Eflornithine, for example, is a drug that has been shown to be ineffective against cancer – but it turns out to inhibit facial hair growth in women and cure a parasitic infection called trypanosomiasis or sleeping sickness. It’s often not immediately obvious why a drug would effectively treat two seemingly different health conditions like these.

There are approximately 2,500 drugs approved by the FDA, and an average of 46 new drugs are approved each year. However, more than 90% of drugs that enter clinical trials fail. This percentage rises to 97% for cancer drugs. Although many shots are needed to produce a viable drug, each failed drug is a candidate for reuse. Researchers like me collected these “failed” compounds for further testing, combing through research papers, patents, and clinical trial databases to find candidates for reuse. Some labs have used artificial intelligence to automate this process.

But it can be difficult to determine which drugs are available for reuse. While a drug development database suggests that there are 47,000 compounds already tested ready for re-use, there is no central repository for this information.

Illustration of various pills falling into an open hand
Analyzing the thousands of drug reuse candidates can be difficult without knowing all of the available options.
smartboy10/DigitalVision Vectors via Getty Images

Marketing Landscape

Drug reuse comes up against an intellectual property barrier. Reuse is more accessible with generic drugs that do not have patents limiting their use for other conditions. But there are fewer opportunities for profit with generics than with new drugs.

Patents allow drug suppliers to have a sales monopoly for a period of time. Repurposed drugs typically receive “use patents” that protect the use of an existing drug for a particular new disease. But companies see this kind of protection as less valuable than a “composition of matter” patent that restricts drug sales to patent holders only. An FDA analysis found that a drug with two drug suppliers resulted in an average price reduction of 39%, and six or more suppliers resulted in a 95% reduction. With less patent protection on a drug, more competitors can enter the market and manufacturers make less money.

Because of this perceived lack of market potential, drug repurposing is typically left to academic institutions that lack the resources to obtain new or repurposed drugs through the costly approval process.

It’s possible that if fluvoxamine was a new drug in development with patent protection at a major pharmaceutical company, it would have already obtained FDA approval to treat COVID-19. But as it stands, fluvoxamine is a widely available generic that any doctor can prescribe “off-label” to treat conditions that haven’t been approved by the FDA, such as COVID-19.

[Over 150,000 readers rely on The Conversation’s newsletters to understand the world. Sign up today.]

This leads to a tragedy of the commons in which no company will invest in the clinical trials needed to bring a repurposed drug to market, because the resulting benefits would be immediately shared with all competitors.

Bringing a new drug to market is a long and expensive process with a high failure rate. When the pharmaceutical industry cannot justify the development of a new drug due to low return on investment, drug repurposing can fill the void. Federal support could make repurposing more commercially attractive, enticing companies to enter the market and boosting this cost-effective way to meet unmet medical needs.

read more
Medical supplies

Surbiton charity helps British-Ukrainian woman deliver medical supplies

A Surbiton charity has loaned its van to a British-Ukrainian woman to help deliver emergency medical supplies to the front line in Ukraine.

After a van hire mix-up, Olga Proto had no vehicle to transport boxes of supplies for Ukraine from Cheam to a collection point in Dover.

She got in touch with the Save The World charity in Surbiton, and the charity’s officials then secured her on their van.

Thanks to the secretary and administrator of the charity Tariq Shabbeer, Olga was able to get vital resources, including Israeli bandages, special tourniquets and catheters, to the border.

Olga, whose parents were once refugees, explained: “My mother is 93 and cried saying, ‘I never thought this would happen again in my country.’

“All that’s happening now is what she saw when she was 11 – the same mass graves.

“Something she never thought she would see again in her lifetime.

“Tariq and Paul from the association were absolutely brilliant.

“They really saved the day.

“I was able to load the van with essential aid for Ukraine and bring it to Dover.”

The medical kit was donated by the public and St Heliers Hospital.

Tariq said: “Olga was really stuck so she came to see us and luckily we were able to help her.

“This is the second delivery to Ukraine that we have supported.”

The supplies crossed the Polish border and were delivered to a convent in Ukraine – with whom Olga has had ties since 2014.

According to Olga, the nuns then distribute the supplies to those who need them most.

Olga has also brought four members of her family to the UK via the government’s new Ukrainian Family Scheme and is very passionate about helping those still suffering in the country.

Her husband paid hundreds of pounds every two months to transport the goods to Ukraine.

read more
Medical products

Veress Needle Market Size, Growth and Forecast

New Jersey, United States – This Veress needle market The report provides detailed market insights to help companies make better business decisions and build growth plans based on market forecasts and trends. The research focuses on group research of data from primary and secondary sources. This Veress Needle Market report explores new developments, trends, and prospects, and forecasts the current status and future prospects of the market from 2022 to 2029. It dives deep into the industry in terms of current and future situations. The research examines a variety of elements, such as degrees of advancement, technical breakthroughs, and various strategies employed by the current major players in the market.

Furthermore, the objective of this market report is to provide a related assessment of key players along with the costs and benefits of the programmed market. It also uses charts to focus on industry standards to help businesses progress smoothly. This market report makes it easy to determine the impact of COVID-19 on the market growth. The main objective of this Veress Needle market report is to include quantitative data in the form of tables and graphs. Knowledge of market fundamentals is presented in a simple and understandable manner for the benefit of readers. This well-planned market analysis provides all readers as well as suppliers, buyers, and stakeholders with a detailed understanding of market conditions and industry environment.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=212073

Key Players Mentioned in the Veress Needle Market Research Report:

CONMED, Fairmont Medical Products Pty Ltd, GRI-Alleset, Grena Ltd., 3-Dmed, Advin Health Care, Changzhou Ankang Medical Instruments Co., Ltd., Duomed Group, Endomed Systems GmbH, Zhejiang Geyi Medical Instrument Co., Ltd. , LOCAMED LIMITED.

This Veress Needle Market report also assesses the economic landscapes of the organization to better understand market dynamics at the international as well as regional levels. This study uses benchmarking to uncover up-to-date information about the target market. The best trading techniques are provided in this report which helps to better understand the market. The latest advancements, growth factors, and competitive analysis are all covered in this Veress Needle market report. He highlighted some of the most effective marketing strategies to drive economic development and help big players reap significant profits.

Segmentation of the Veress needle market:

Veress Needles Market, By Type

• 120mm
• 150mm
• Others

Veress Needles Market, By Application

• Gynecological surgery
• Urological surgery
• General surgery

The market research analysis further talks about the industry forces to shape the market. Important drivers and end user expectation are also discussed in Veress Needle market report to get solutions. The forecast of associated revenue is also made in the report. The main purpose of the report is to categorize opportunities. It also explains what business models are used, what is the current level of success, what is the market share and size, and what is the current level of competition in the market. It also sheds light on the functional areas of the business. This Veress Needle market report also shows how dead inventory affects profits and how product losses can be eliminated. With the business tactics provided here, it is possible to experience accelerated growth in your business. It also provides a clear picture of how different business sectors are experiencing the negative impact of COVID-19.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=212073

Scope of the Veress Needles Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

Determining the pulse of the market becomes easy with this detailed analysis of the Veress Needle market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the Veress Needle market?

2. How will the Veress needle market evolve over the next five years?

3. Which product and which application will take the lion’s share of the Veress needle market?

4. What are the drivers and restraints of the Veress Needle Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Veress Needle market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/veress-needle-market/

Visualize the Veress Needle Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Veress needle market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. etc

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Swabs Market Size, Growth and Forecast

New Jersey, United States – This swab market The report provides detailed market insights to help companies make better business decisions and build growth plans based on market forecasts and trends. The research focuses on group research of data from primary and secondary sources. This Swab Market report explores new developments, trends, and outlook, and forecasts the current status and future outlook of the market from 2022 to 2029. It dives deep into the industry in terms of current and future situations. The research examines a variety of elements, such as degrees of advancement, technical breakthroughs, and various strategies employed by the current major players in the market.

Furthermore, the objective of this market report is to provide a related assessment of key players along with the costs and benefits of the programmed market. It also uses charts to focus on industry standards to help businesses progress smoothly. This market report makes it easy to determine the impact of COVID-19 on the market growth. The main objective of this Swab market report is to include quantitative data in the form of tables and graphs. Knowledge of market fundamentals is presented in a simple and understandable manner for the benefit of readers. This well-planned market analysis provides all readers as well as suppliers, buyers, and stakeholders with a detailed understanding of market conditions and industry environment.

Get Sample Full PDF Copy of Report: (Including Full Table of Contents, List of Tables and Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=23805

Key Players Mentioned in the Swabs Market Research Report:

Puritan Medical Products, Sarstedt, MWE, SARSTEDT AG & Co, Lab M Limited., Clean Cross Co. Ltd., GPC medical ltd., Citotest Labware Manufacturing Co., Ltd. and Q-TIPS, ELMEX.

This Swabs Market report also assesses the economic landscapes of the organization to better understand the market dynamics at the international as well as regional levels. This study uses benchmarking to uncover up-to-date information about the target market. The best trading techniques are provided in this report which helps to better understand the market. The latest advancements, growth factors, and competitive analysis are all covered in this Swab Market report. He highlighted some of the most effective marketing strategies to drive economic development and help big players reap significant profits.

Swabs Market Segmentation:

Swabs Market, By Application

• Pharmaceutical
• Microbiological
• Laboratory
• Others

Swab market, by well

• Aluminum
• Polypropylene
• Others

Swabs Market, By Test Type

• DNA test
• Urine test
• Saliva test
• Others

The market research analysis further talks about the industry forces to shape the market. Important drivers and end user expectation are also discussed in the Swabs market report to get solutions. The forecast of associated revenue is also made in the report. The main purpose of the report is to categorize opportunities. It also explains what business models are used, what is the current level of success, what is the market share and size, and what is the current level of competition in the market. It also sheds light on the functional areas of the business. This Swabs market report also shows how dead inventory affects profits and how product losses can be eliminated. With the business tactics provided here, it is possible to experience accelerated growth in your business. It also provides a clear picture of how different business sectors are experiencing the negative impact of COVID-19.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=23805

Scope of Swabs Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the swabs market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the Top Five Swab Market Players?

2. How will the swab market evolve over the next five years?

3. Which product and application will occupy the lion’s share of the swab market?

4. What are the Swab Market drivers and restraints?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Swab market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/swab-market/

Visualize the swab market using verified market intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize Swab Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. etc

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical products

Personal Mobility Devices Market Size, Growth and Forecast

New Jersey, United States – This personal mobility device market The report provides detailed market insights to help companies make better business decisions and build growth plans based on market forecasts and trends. The research focuses on group research of data from primary and secondary sources. This Personal Mobility Devices Market report explores the new developments, trends and prospects, and forecasts the current status and future prospects of the market from 2022 to 2029. It dives deep into the industry in terms of current and future situations . The research examines a variety of elements, such as degrees of advancement, technical breakthroughs, and various strategies employed by the current major players in the market.

Furthermore, the objective of this market report is to provide a related assessment of key players along with the costs and benefits of the programmed market. It also uses graphics to focus on industry standards to help businesses progress smoothly. This market report makes it easy to determine the impact of COVID-19 on the market growth. The main objective of this Personal Mobility Devices market report is to include quantitative data in the form of tables and graphs. Knowledge of market fundamentals is presented in a simple and understandable manner for the benefit of readers. This well-planned market analysis provides all readers as well as suppliers, buyers, and stakeholders with a detailed understanding of market conditions and industry environment.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=37564

Key Players Mentioned in the Personal Mobility Devices Market Research Report:

NOVA Medical Products, Performance Health, Drive DeVilbiss Healthcare, Medline Industries Invacare Corporation, Carex Health Brands Kaye Products Rollz International, GF HEALTH PRODUCTS and Briggs Healthcare

This Personal Mobility Devices Market report also assesses the economic landscapes of the organization to better understand market dynamics at international and regional levels. This study uses benchmarking to uncover up-to-date information about the target market. The best trading techniques are provided in this report which helps to better understand the market. The latest advancements, growth factors, and competitive analysis are all covered in this Personal Mobility Devices market report. He highlighted some of the most effective marketing strategies to drive economic development and help big players reap significant profits.

Personal Mobility Devices Market Segmentation:

Personal Mobility Devices Market, By Product

• Wheel chairs
• Scooters
• Walking aids

The market research analysis further talks about the industry forces to shape the market. Important drivers and end user expectation are also covered in the Personal Mobility Devices market report to get solutions. The forecast of associated revenue is also made in the report. The main purpose of the report is to categorize opportunities. It also explains what business models are used, what is the current level of success, what is the market share and size, and what is the current level of competition in the market. It also sheds light on the functional areas of the business. This Personal Mobility Devices market report also shows how dead stock affects profits and how product losses can be eliminated. With the business tactics provided here, it is possible to experience accelerated growth in your business. It also provides a clear picture of how different business sectors are experiencing the negative impact of COVID-19.

Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=37564

Scope of the Personal Mobility Devices Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
FORECAST YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD/billion)
SECTORS COVERED Types, applications, end users, and more.
REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

It becomes easy to determine the pulse of the market with this detailed analysis of the Personal Mobility Devices market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

Answers to key questions in the report:

1. Who are the top five players in the personal mobility device market?

2. How will the personal mobility device market evolve in the next five years?

3. Which products and applications will capture the lion’s share of the personal mobility device market?

4. What are the drivers and restraints of the Personal Mobility Devices Market?

5. Which regional market will show the strongest growth?

6. What will be the CAGR and size of the Personal Mobility Devices market throughout the forecast period?

For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/personal-mobility-devices-market/

Visualize the Personal Mobility Devices Market Using Verified Market Intelligence:-

Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

Visualize the Personal Mobility Devices Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. etc

At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

read more
Medical supplies

Army seizes weapons and medical supplies from Boko Haram and ISWAP terrorists

By Timothy Olanrewaju Maiduguri

Military troops from the Northeast Counter-insurgency Operation captured large weapons and ammunition from Boko Haram and ISWAP during an offensive on insurgent positions in Borno State

Chief of Army Staff (COAS), Lt. Gen. Faruk Yahaya while inspecting weapons at Maimalari Cantonment of Nigerian Army Division 7, Maiduguri, said yesterday that the weapons and other items had been seized in the mountains of Sambisa, Tumbus and Màndara; the locations of terrorists in Borno State.

“The result of what we did is what you see here where we got all these weapons from the terrorists, including from the mountains of Sambisa, Tumbus and Mandara,” he revealed.

The army chief said he was impressed by the troops’ sustained offensive against the terrorist enclave which led to the recovery of some operational vehicles previously seized from troops, first aid boxes and other items.

He congratulated the troops in the theater of operations and other military operations across the country for their commitment.

“I am very impressed with what the troops are doing in theater and in other operations in the northwest, north-central and southeast.

Often there are difficulties and challenges are part of the operation,” he said.

He vowed that the army and military would not be discouraged by recent challenges.

He urged the insurgents to follow the path of peace and give up the fight

read more
Prescription drugs

5 ways to save on prescription drugs

The pandemic has prompted more Americans to shop online, and buying drugs is no exception. In addition to the mail-order business of major chains, such as CVS and Walgreens, and established online vendors, such as Amazon and Costco.com, there are now many newcomers to online pharmacy, including GeniusRx, Honeybee Health, Ro Pharmacy, ScriptCo Pharmacy, and Mark Cuban Cost Plus Drug Co.

But while in many cases they offer rock bottom prices, buying drugs online isn’t the only way to save. Here are some more.

1. Use GoodRx coupons at a walk-in pharmacy

GoodRx is a company that provides free coupons that give you discounts on drugs. Available on its website or through the GoodRx app, the coupons can save you 80% off the list price of generic drugs at select pharmacies. For more savings, consider joining the GoodRx Gold program, which gives you access to over 1,000 medications for less than $10 per prescription. An individual membership costs $10 per month; for $20 a month you can add five family members, friends or even pets. Bonus: Master Gold account holders also get telehealth medical visits for as little as $19.

2. Check out discount programs at Walgreens and Walmart

Enrolling in the Walgreens Prescription Savings Club program allows you to fill prescriptions for hundreds of generic medications for $7.50, $10, or $15 for a 30-day supply, or $15, $20, or $30 for a 90 day supply – no insurance needed. Membership costs $20 per year for an individual or $35 for a family. Walmart’s free prescription program offers dozens of medications for $4 for a one-month supply or $10 for a 90-day supply. Bonus: Supermarkets like Kroger, HEB and others also offer discounted generic drug programs. Check those in your area for details.

3. Look for generics offered by your insurer

If you have an Aetna health insurance plan, for example, you can use the Aetna Rx Discount Pharmacy Card (PDF) at participating pharmacies in the insurer’s network to get preferred rates.

Call the number on the back of your insurance card to find a pharmacy near you. Or if your drug coverage is through CVS/Caremark, you can get discounts on several dozen select generics if you fill the prescription at a CVS pharmacy or through CVS.com.

4. Look for co-pay coupons or patient assistance programs

Getting a discount off the spot price of a brand name drug is a little trickier than getting a generic, but it’s still possible.

Drug companies offer copayment reduction programs if you sign up, but only if you have insurance. For people whose incomes reach certain thresholds, a pharmaceutical company’s assistance program can provide drugs for free, even to some people without insurance.

You can find manufacturer rebate programs for brand name drugs on the GoodRx website or app.

Bonus: Check out NeedyMeds for free assistance finding and filing documents for many manufacturer programs.

5. Ask your local pharmacy for a discount

Unlike chain pharmacies, which have set spot prices, your community pharmacy may have more leeway when it comes to drug pricing, says Doug Hoey, PharmD, CEO of the National Community Pharmacists Association. And Brandy Letson, PharmD, owner of Cashiers Valley Pharmacy in Cashiers, NC, says your local independent pharmacy can sometimes match or even beat low prices at a chain or online pharmacy, but you have to ask.

Editor’s note: This article also appeared in the May 2022 issue of Consumer Reports magazine.

Consumer Reports has no financial relationship with the advertisers on this site.

More from Consumer Reports:
Best tires for 2016
Best Used Cars Under $25,000
7 Best Mattresses for Couples

Consumer Reports is an independent, nonprofit organization that works alongside consumers to create a fairer, safer and healthier world. CR does not endorse products or services and does not accept advertising. Copyright © 2022, Consumer Reports, Inc.

read more
Prescription drugs

Framingham Police will take back unwanted prescription drugs on April 30

FRAMINGHAM – Residents can rid their homes of potentially dangerous expired, unused and unwanted prescription drugs on Saturday, April 30, when the Framingham Police Department (FPD) and Medical Reserves Corp hold Drug Take Back Day, a free drive-thru and anonymous service.

Held from 10 a.m. to 2 p.m. in the municipal parking lot at 1 William Welch Way, the program aims to prevent drug abuse and theft by accepting pills, patches, liquids and ointments for disposal.

No questions will be asked regarding ownership of articles and entrants will be anonymous.

This initiative addresses a vital public safety and public health issue, according to Kitty Mahoney, Chief Public Health Nurse for the City of Framingham.

“Medicines that languish in household cupboards are highly susceptible to being diverted, misused and abused,” she said. “Rates of prescription drug abuse in the United States are alarming, as are the number of accidental poisonings and overdoses from these drugs.”

Studies show that the majority of prescription drugs abused come from family and friends, including home medicine cabinets.

Other disposal methods, such as flushing the drugs down the toilet or throwing them in the trash, pose safety and health risks.

If you have any questions, please contact Mahoney at 508-532-5472.


This press release was produced by the City of Framingham. The opinions expressed here are those of the author.

read more
Medical products

Surgical Swabs Market Impact and Recovery Analysis Puritan Medical Products, 3M, Dynarex, Copan Diagnostics, BD – Business Merseyside

The research report on Surgical Swabs Market is a professional asset that provides dynamic and statistical insights into the regional and global markets. It includes an in-depth study of the current scenario to safeguard market trends and prospects. Surgical swab research reports also keep track of future technologies and developments. Detailed information about new products, regional and market investments are provided in the report. This surgical swab research report also examines all the elements businesses need to gain unbiased data to help them understand the threats and challenges facing their business. The Healthcare Industry report further includes market gaps, stability, growth drivers, restraining factors, and opportunities over the forecast period.

Get a sample report with table and charts: www.a2zmarketresearch.com/sample?reportId=529762

“Surgical Swab is growing at a good CAGR over the forecast period. The growing interest of individuals in the healthcare industry is one of the main reasons for the expansion of this market. »

Major Companies in this report are: Puritan Medical Products, 3M, Dynarex, Copan Diagnostics, BD, Advacare Pharma, DLS Medical, FL MEDICAL srl

Presentation of the report:

* The report analyzes regional growth trends and future opportunities.

* Detailed analysis of each segment provides relevant information.

* The data collected in the report is researched and verified by analysts.

* This report provides realistic information on supply, demand and future forecasts.

Surgical Swabs Market Overview:

This systematic research study provides an in-depth assessment of the Surgical Swabs market while offering significant fragments of knowledge, chronic information, and measurably maintained industry-approved healthcare market conjecture. Additionally, a controlled and formal set of assumptions and strategies were used to construct this in-depth review.

Segmentation

The report offers an in-depth assessment of the Surgical Swabs market strategies, geographic and business segments of major market players.

Type

Cotton swabs, foam swabs, non-woven swabs, others

Application

Hospitals and clinics, laboratories and diagnostic centers, research institutes

During the crafting of this Surgical Swabs research report, the driving factors of the market are studied. It also provides information on market constraints to help clients build successful businesses. The report also discusses key opportunities.

Get a discount: www.a2zmarketresearch.com/discount/529762

This report provides an in-depth and broad understanding of the surgical swab. With precise data covering all the key characteristics of the current market, the report offers detailed data from key players. An audit of the state of the market is mentioned as accurate historical data for each segment is available during the forecast period. The driving force, restraints, and opportunities are provided to help provide an improved picture of this investment in the market over the forecast period 2022-2027.

Some Key Objectives of the Surgical Swabs Market Research Report:

oh Vital developments: The Custom Survey provides the critical Surgical Swabs Market improvements including R&D, shipment of new items, coordinated efforts, development rate, partnerships, joint efforts, and local development of rivals working on the global and regional healthcare market.

oh Market characteristics: The report contains Surgical Swabs Market Highlights, Revenue, Boundary, Boundary Utilization Rate, Value, Net, Creation Rate, Generation, Utilization, Import, Trade, supply, demand, cost, part of the industry in general, CAGR and gross margin. Likewise, the market report offers an exhaustive investigation of the most recent elements and their patterns, as well as fragments and sub-sections of the Healthcare market.

oh Survey tools: This market report incorporates the precisely considered and assessed information about the major established players and their extension in the Surgical Swabs market by methods. Systematic tools and methodologies for example Porter’s Five Powers Survey, Possibility Study, and many other statistical survey methods have been used to analyze the development of major players working in the Surgical Swabs market .

oh Convincingly, the Surgical Swabs report will give you an unequivocal perspective on every market reality without the need to allude to any other research report or information source. This report will provide you all with the realities of the past, present and future fate of the healthcare market.

Buy exclusive reports: www.a2zmarketresearch.com/buy?reportId=529762

If you have any special requirements, please let us know and we will offer you the report you want.

Contact us:

Roger Smith

1887 WHITNEY MESA DR HENDERSON, NV 89014

[email protected]

+1 775 237 4147

Related reports:

Patent and Trademark Renewal Services Market Share Forecast Global Impact of Competitors

Global Industrial Analytics Market Research Forecast Impact

Global Cleanroom Robots Market Research Forecast Impact

Emulsion Explosives Market Impact, Share Discount Industry Competitors Globally | Orica, IPL, MAXAM, AEL

Emulsion Explosives Market 2022: Business Development, Size, Share and Opportunities 2026

Targeted Therapeutics Market 2022

Reabastecimiento de combustible aire-aire Market 2022: Desarrollo de Negocios, Tamaño, Participación y Oportunidades 2026 Omega Air Refueling Services, Eaton Corporation, Airbus SAS

Spatial Augmented Reality (SAR) Market 2022: Business Development, Size, Share and Opportunities 2026 Intermap Technologies, Autodesk, Cybercity 3D

Dispositivos de oncología interventionista Market 2022: Desarrollo de Negocios, Tamaño, Participación y Oportunidades 2026 Cook Medical, Merit Medical Systems, Boston Scientific Corporation

read more
Medical supplies

Ukrainian church seeking cash donations and medical supplies

St. Mary’s Ukrainian Orthodox Church has a growing pile of donated used clothing in the back of its communion hall.

Clothing will be put to good use, according to Church President Sohpia Torcivia. But what the church really wants right now is medicine, money, and gun holsters, if you have them.

“These are still needed,” Torcivia said.

St. Mary’s has been collecting donations to help Ukraine since Russia invaded the country in February. Now they really try to focus on certain elements.

Torcivia said a partner that helps move donated items to Ukraine isn’t even accepting used clothes anymore.

Their needs, she said, are mainly cash and medical supplies, such as bandages and iodine. They will also be happy to take all used body armor, belts and male underwear.

Cash donations, Torcivia said, will pay to ship medical supplies and other items.

Past church president Jim Harasymiw helped with St. Mary’s giving campaign.

He has been coming to church since 1953, when he was only eight years old. His family fled Ukraine during World War II, first to Germany, then to Milwaukee.

Once a refugee, he now tries to give back to his native Ukraine.

“I feel like crying. You know, I’m watching TV and the Russians are grabbing prisoners, Ukrainian prisoners and shooting them,” Harasymiw said. “And it’s like it could have been my family.”

If you have used clothes you’d like to donate to St. Mary’s, go ahead. Torcivia said he’ll be going to a local shelter, or they might have some sort of garage sale soon when the weather warms up.

All of the items will be free, though she said a donation of a dollar or two would go a long way in shipping more items to people in need in Ukraine.

You can find out how to donate by visiting the Facebook page.

Report a typo or error // Submit a news tip

read more
Prescription drugs

Residents of Orcas Island can get rid of prescription drugs at the next Take-Back event

The Coalition for Orcas Youth (COY) is hosting an event to help prevent opioid abuse in the community


||| BY NICOLE SPINOGATTI for COALITION FOR ORCAS YOUTH |||


The Coalition for Orcas Youth (COY) will be hosting a prescription drug take-back event on Saturday, April 30, 10 a.m. to 2 p.m., at Key Bank Drive Thru 487 Main St, Eastsound. This event allows the public to dispose of unused or expired prescription medications in a safe and easy way. Both prescription and over-the-counter medications will be accepted. Medications can remain in their original container and labels do not need to be removed. Medications that are not in their original container will also be accepted.

This recovery event supports a Washington State Health Care Authority campaign called Starts with One. This campaign informs and educates young adults, their parents and the elderly about the dangers of prescription drug abuse and the importance of safe storage and disposal of prescription opioids.

According to the campaign’s website, “75% of opioid abuse begins with people using drugs that weren’t prescribed to them – usually taken by a friend or family member.” Simple measures, such as the safe disposal of medications, can prevent them from being misused.

Participating in these recovery events is something individuals can do to help fight the opioid epidemic and protect their loved ones.

For more information on the HCA Starts with One campaign, visit www.getthefactsrx.com. For more information about the Coalition for Orcas Youth, visit coalitionfororcasyouth.org.


read more
Prescription drugs

Mark Cuban wants to sell you cheaper (prescription) drugs

Sometimes it seems like all the big tech giants are talking about disrupting healthcare. Apple (AAPL) – Get the Apple Inc. wants to do it, Amazon (AMZN) – Get the report from Amazon.com, Inc. bought an online pharmacy, and even Haven a partnership, between Berkshire Hathaway’s (BRK.A) – Get the Berkshire Hathaway Inc. Class A report. Warren Buffett, JPMorgan’s (JPM) – Get the JPMorgan Chase & Co. report.and Amazon, have tried (and failed) this gargantuan task.

Perhaps the problem is that all of these approaches have been huge swings – massive attempts to disrupt a deeply entrenched industry.

Enter Mark Cuban.

The outspoken billionaire owner of the Dallas Mavericks has decided to take a very basic business approach to disrupting healthcare and drug prices. He got rid of the middleman. His company, the humbly named “Mark Cuban Cost Plus Drug Company” had very clear goals and a very simple approach.

“We started Mark Cuban Cost Plus Drug Company because every American should have access to safe and affordable drugs. If you don’t have insurance or have a high deductible plan, you know that even the most basics can cost a fortune. Many people spend crazy amounts of money every month just to stay healthy. No American should have to suffer or worse – because they can’t afford basic medicines. prescription,” the company shared on its website.

How Mark Cuban’s Pharmaceutical Company Works

Cuban wants to offer drugs at low prices, but he also wants transparency so customers can see what they’re paying for. The company started by looking at one drug, Albendazole, a drug used to treat hookworm, which may be a problem “for disadvantaged populations,” according to Cost Plus.

“Normally, the prescribed drug for hookworm, albendazole, can cost up to $500 per treatment, making the drug out of reach for many people in need,” the company explained.

Scroll to continue

In reality, it only costs $26.08 per course.

“We are marking up this price by 15% so that we can continue to run the business and invest to disrupt the price of as many drugs as possible,” Cost Plus added.

“Our goal is to dramatically reduce the cost of drugs like Albendazole, but we also believe it is equally important to introduce transparency into drug pricing so patients know they are getting a fair price” , explained the company. basic drug price $30. Then we add the actual cost, $3, that our pharmaceutical partners charge us to compound and deliver your prescription to you.

This makes the final price to consumers $33.

“Every product we sell is priced the same as our cost plus 15% plus pharmacy fees,” the company added.

Mark Cuban Cost Plus offers hundreds of medications and shares full price transparency on its website. The company has also just launched an online community on Twitter where people can share their drug pricing experiences.

Twitter reacts to Mark Cuban Cost Plus Drug Company

Instead of finding a bold new way to disrupt all health care, Cuban tackled a real part of the problem. Twitter (TWTR) – Get the report from Twitter, Inc.as you can imagine, love what Cuba does.

Cuban also shared the link to join the Cost Plus Drugs online community.

read more
Medical supplies

Woodbridge Police donate ballistic vests and medical supplies to Ukraine

Photo by Liz Hardaway


Constable Brian Pedalino, left, Yuriy Faryna, center, and Constable Joseph Kubik stand with body armor and medical supplies donated by the Woodbridge Police Department to help Ukraine.

Woodbridge Police Department/Contributing Photo

WOODBRIDGE — Members of the Woodbridge Police Department have donated numerous ballistic vests and medical supplies to Ukrainians as they continue to fight the Russian invasion, the police department said Friday.

Several weeks ago, Officer Joseph Kubik reached out to his Ukrainian friend and Woodbridge resident Yuriy Faryna about how to help the Ukrainian people.

Faryna, who was born in Ukraine and moved to the United States in 2001, has many family members and friends who still live in the now war-torn country. Faryna told Kubik that the Ukrainians urgently needed ballistic vests and medical supplies.


“The Woodbridge Police Department would like to show its support for the Ukrainian community,” the police department said Friday. “We hope our small gesture will encourage others to show their support for the Ukrainian people.”

Less than two weeks ago, several Connecticut police departments donated more than 200 previously worn ballistic vests and dozens of helmets to the Ukrainian American Coordinating Council, according to a previous report. Police in Hamden and New Haven have made similar donations in previous weeks.

Ukrainians still need additional equipment, in particular level 4 ballistic vests and helmets, police said. Any residents wishing to donate any of these items should contact Kubik at [email protected] or Officer Brian Pedalino at [email protected]

read more
Medical products

Laser manufacturing of high precision medical products

By Matthew Nipper, Spectrum Plastics Group, Director of Engineering

Laser micromachining is one of the highest precision processes used in the manufacturing of medical devices. In fact, lasers are often the only option capable of producing certain delicate features, especially in thin or sensitive materials. Lasers can quickly cut micron-sized features to sub-micron tolerances without defects, thereby reducing or eliminating secondary finishing processes, shortening cycle times and accelerating time to market. Because of these advantages, lasers are quickly becoming the preferred method for micro-machining miniaturized and/or complex parts and products for medical devices, in virtually any shape or pattern.

Innovative product designs that require microscopic features are often best produced using laser machining, for example, catheters, medical balloons, and devices for neurovascular, cardiovascular, and diagnostic procedures. Features produced in polymers can be as small as 10 microns in width, with tolerances as tight as 1-2 microns.

Polymers are the material of choice for many medical devices. These materials are mechanically robust, bioinert and have excellent insulating properties. Polymers can be engineered to exhibit specific mechanical and chemical characteristics, to improve biocompatibility and performance, and can be extruded, injection molded or additively manufactured. Virtually any thermoplastic or thermoset polymer material can be laser processed with high precision, including polycarbonate, polyurethanes, ABS, FEP, polyamides, polyimides, PEEK, PTFE, PMMA, polyester , nylon, PE and acrylics.

laser methods

As products become smaller and more complex, engineers must use their technical skills, materials knowledge, and experience to design processes that can create tiny, high-precision features that enhance product functionality, which can ultimately improving or saving the lives of patients.

Here are examples of commonly used high-precision laser methods:

laser removal

Lasers can be programmed to remove or “vaporize” material from surfaces with sub-micron precision. Ablation selectively removes substrate or coating layers from the surface of fabricated parts, with little or no negative thermal or structural impacts on the surrounding material.

Laser cut

Laser cutting is ideal for manufacturing/industrial applications that require a powerful, highly precise cutting tool that creates sharp features on a microscopic scale. As products become smaller, with more functionality, complexity and tight tolerances, laser cutting is often the only method that can produce the high precision features these devices require.

Laser drilling

Many manufactured parts today require microscopic features that can only be created with laser drilling. This highly adaptable, versatile and reliable microfabrication process is used in a wide range of industries. Laser fabrication and post-laser processing can be customized to meet unique drilling needs, optimizing applications such as micro-holes, hole arrays, blind holes and specialty portals. Micron-scale holes can be laser drilled in a variety of patterns with the utmost precision, with no burrs or residual material to clog the holes.

wire stripping

Wire stripping removes sections of insulation or shielding from wires and cables to provide electrical contact points for termination. Conventional stripping methods make physical contact with the conductor, which can damage the wire and slow processing speed. Laser wire stripping is much faster, offers excellent accuracy and process control, and eliminates wire contact, allowing the processing of gauges as small as 46 AWG (0.0015 inches in diameter).

Ultra-fast lasers

Ultra-fast lasers are in high demand due to their speed, accuracy, and lack of thermal or structural damage to the material being processed. With an average pulse width of 150 femtoseconds (150 quadrillionths of 1 second), there is virtually no heat transfer beyond the dimensions of the cut, making it a “cold” process. Therefore, secondary processing is usually not required to remove burrs from cutters or improve edge quality, saving time and money.

Components and laser technology

Precision laser processing can be used for extruded medical tubing, catheters and drug delivery products, medical balloons, injection molding and flexible films. For example:

  • Extruded medical tube. Lasers are high-precision machining instruments that cut micron-scale features in extruded tubing that enable specific medical applications, such as intravascular delivery of drugs or stents. Extruded medical tubing is a commonly used component in medical devices. It is made from a variety of materials and in a wide range of shapes and sizes. Important chemical and mechanical properties include heat and chemical resistance, lubricity, flexibility, kink resistance, and drug eluting capabilities.
  • Catheter technologies. The lasers, which offer high speeds, incredible precision and the ability to process without thermally altering the surrounding material, are ideal for removing material by ablation or drilling a variety of micron-sized features in tubing. catheter and other materials. As medical catheters become smaller and more complex, lasers are often the only manufacturing technology capable of providing the precision needed.
  • Medical balloons. Lasers play a vital role in creating detailed, high-precision medicine ball features that no other method can replicate, including; texturing, grooving and section thinning. With the latest laser technologies, tools, and materials, medicine balloons can be fabricated with microscale features, from a wide variety of materials, for neurovascular, cardiovascular, gastrointestinal, urology, and catheterization procedures. increasingly innovative.
  • Injection molding. For injection molded products, lasers can be used to create micron-sized features in molds, process molded ophthalmic implants, and improve osseointegration of injection molded bioresorbable implants. Because ultra-fast lasers cause no thermal damage, they are ideal for treating sensitive implantable and bioresorbable materials.
  • Flexible films. Laser processing can be used for a variety of film applications. For example, lasers can be used to create surface micro-texture patterns on thin films increasing adhesion in delicate bonding applications. Lasers are also ideal for drilling small features, such as dense arrays of holes in filters or spargers. These are often made from thermoplastic materials, which are very heat sensitive.

Spectrum laser processing

As a full-service laser solutions provider, Spectrum can manufacture high-precision parts to exact specifications in the most efficient and cost-effective manner. Spectrum excels at turning even seemingly impossible designs into high-value products that exceed customer expectations.

Not only is Spectrum a contract manufacturer of high precision laser products, but we also supply ready made laser die tubes and laser cut marking tapes online at online store.spectrumplastics.com, which can be used to speed up the development phase of your next project. For more information on Spectrum’s services and laser processing capabilities, visit www.spectrumplastics.com or call 404-564-8560.

Content sponsored by Spectrum Plastics Group

read more